| Year |
Citation |
Score |
| 2024 |
Befano B, Wentzensen N, Lorey T, Poitras N, Cheung LC, Schiffman M, Clarke MA, Cohen C, Kinney W, Locke A, Castle PE. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California. Gynecologic Oncology. 184: 89-95. PMID 38301311 DOI: 10.1016/j.ygyno.2024.01.038 |
0.64 |
|
| 2024 |
Desai KT, Hansen N, Rodriguez AC, Befano B, Egemen D, Gage JC, Wentzensen N, Lopez C, Jeronimo J, de Sanjose S, Schiffman M. Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs. Preventive Medicine. 180: 107881. PMID 38286273 DOI: 10.1016/j.ypmed.2024.107881 |
0.337 |
|
| 2024 |
de Sanjosé S, Perkins RB, Campos N, Inturrisi F, Egemen D, Befano B, Rodriguez AC, Jerónimo J, Cheung LC, Desai K, Han P, Novetsky AP, Ukwuani A, Marcus J, Ahmed SR, ... ... Schiffman M, et al. Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy. Elife. 12. PMID 38224340 DOI: 10.7554/eLife.91469 |
0.588 |
|
| 2023 |
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. 2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023. Journal of Lower Genital Tract Disease. 28: 3-6. PMID 38117563 DOI: 10.1097/LGT.0000000000000788 |
0.363 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, ... ... Schiffman M, et al. Reproducible and clinically translatable deep neural networks for cervical screening. Scientific Reports. 13: 21772. PMID 38066031 DOI: 10.1038/s41598-023-48721-1 |
0.505 |
|
| 2023 |
Perkins RB, Wentzensen N, Schiffman M. Primary HPV Screening vs Cotesting for Cervical Cancer-Reply. Jama. 330: 2121-2122. PMID 38051330 DOI: 10.1001/jama.2023.20373 |
0.649 |
|
| 2023 |
Desai KT, de Sanjosé S, Schiffman M. Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research. Cancer Prevention Research (Philadelphia, Pa.). 16: 649-651. PMID 38037384 DOI: 10.1158/1940-6207.CAPR-23-0448 |
0.643 |
|
| 2023 |
Parham GP, Egemen D, Befano B, Mwanahamuntu MH, Rodriguez AC, Antani S, Chisele S, Munalula MK, Kaunga F, Musonda F, Malyangu E, Shibemba AL, de Sanjose S, Schiffman M, Sahasrabuddhe VV. Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation. Infectious Agents and Cancer. 18: 61. PMID 37845724 DOI: 10.1186/s13027-023-00536-5 |
0.586 |
|
| 2023 |
Inturrisi F, de Sanjosé S, Desai KT, Dagnall C, Egemen D, Befano B, Rodriguez AC, Jeronimo JA, Zuna RE, Hoffman A, Farhat Nozzari S, Walker JL, Perkins RB, Wentzensen N, Palefsky JM, ... Schiffman M, et al. A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study. International Journal of Cancer. PMID 37772799 DOI: 10.1002/ijc.34698 |
0.707 |
|
| 2023 |
de Sanjosé S, Perkins RB, Campos NG, Inturrisi F, Egemen D, Befano B, Rodriguez AC, Jerónimo J, Cheung LC, Desai K, Han P, Novetsky AP, Ukwuani A, Marcus J, Ahmed SR, ... ... Schiffman M, et al. Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy. Medrxiv : the Preprint Server For Health Sciences. PMID 37693492 DOI: 10.1101/2023.08.30.23294826 |
0.554 |
|
| 2023 |
Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical Cancer Screening: A Review. Jama. 330: 547-558. PMID 37552298 DOI: 10.1001/jama.2023.13174 |
0.473 |
|
| 2023 |
Gradissimo A, Clarke MA, Xue X, Castle PE, Raine-Bennett TR, Schiffman M, Wentzensen N, Strickler HD, Burk RD. A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma. Journal of the National Cancer Institute. PMID 37467068 DOI: 10.1093/jnci/djad134 |
0.61 |
|
| 2023 |
Schiffman M, Mirabello L, Egemen D, Befano B, Xiao Y, Wentzensen N, Raine-Bennett T, Nayar R, Cheung LC, Rositch A, Beaty T, Perkins RB, de Sanjose S, Lorey T, Castle PE, et al. The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma. Gynecologic Oncology. 174: 253-261. PMID 37243996 DOI: 10.1016/j.ygyno.2023.05.011 |
0.688 |
|
| 2023 |
Perkins RB, Smith DL, Jeronimo J, Campos NG, Gage JC, Hansen N, Rodriguez AC, Cheung LC, Egemen D, Befano B, Novetsky AP, Martins S, Kalpathy-Cramer J, Inturrisi F, Ahmed SR, ... ... Schiffman M, et al. Use of risk-based cervical screening programs in resource-limited settings. Cancer Epidemiology. 84: 102369. PMID 37105017 DOI: 10.1016/j.canep.2023.102369 |
0.372 |
|
| 2023 |
Befano B, Campos NG, Egemen D, Herrero R, Schiffman M, Porras C, Lowy DR, Rodriguez AC, Schiller JT, Ocampo R, Hildesheim A, Sampson JN, Das S, Kreimer AR, Cheung LC. Estimating human papillomavirus vaccine efficacy from a single-arm trial: Proof-of-principle in the Costa Rica Vaccine Trial. Journal of the National Cancer Institute. PMID 37040086 DOI: 10.1093/jnci/djad064 |
0.41 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, ... ... Schiffman M, et al. Reproducible and Clinically Translatable Deep Neural Networks for Cancer Screening. Research Square. PMID 36909463 DOI: 10.21203/rs.3.rs-2526701/v1 |
0.508 |
|
| 2022 |
Lou H, Boland JF, Li H, Burk R, Yeager M, Anderson SK, Wentzensen N, Schiffman M, Mirabello L, Dean M. HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation. Cancers. 14. PMID 36230818 DOI: 10.3390/cancers14194895 |
0.542 |
|
| 2022 |
Kelly H, Jaafar I, Chung M, Michelow P, Greene S, Strickler H, Xie X, Schiffman M, Broutet N, Mayaud P, Dalal S, Arbyn M, de Sanjosé S. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis. Eclinicalmedicine. 53: 101645. PMID 36187721 DOI: 10.1016/j.eclinm.2022.101645 |
0.413 |
|
| 2022 |
Castle PE, Befano B, Schiffman M, Wentzensen N, Lorey T, Poitras N, Hyer M, Cheung LC. A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening. Preventive Medicine. 162: 107157. PMID 35810936 DOI: 10.1016/j.ypmed.2022.107157 |
0.58 |
|
| 2022 |
Desai KT, Adepiti CA, Schiffman M, Egemen D, Gage JC, Wentzensen N, de Sanjose S, Burk RD, Ajenifuja KO. Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management. International Journal of Cancer. PMID 35666530 DOI: 10.1002/ijc.34151 |
0.681 |
|
| 2022 |
Hu SY, Kreimer AR, Porras C, Guillén D, Alfaro M, Darragh TM, Stoler MH, Villegas LF, Ocampo R, Rodriguez AC, Schiffman M, Tsang SH, Lowy DR, Schiller JT, Schussler J, et al. Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial. Journal of the National Cancer Institute. PMID 35640980 DOI: 10.1093/jnci/djac107 |
0.586 |
|
| 2022 |
Adebamowo SN, Befano B, Cheung LC, Rodriguez AC, Demarco M, Rydzak G, Chen X, Porras C, Herrero R, Kim JJ, Castle PE, Wentzensen N, Kreimer AR, Schiffman M, Campos NG. Different Human Papillomavirus Types Share Early Natural History Transitions in Immunocompetent Women. International Journal of Cancer. PMID 35603904 DOI: 10.1002/ijc.34128 |
0.709 |
|
| 2022 |
Sahasrabuddhe VV, Castle PE, Schiffman M, Wentzensen N, Heckman-Stoddard B, Arbyn M. Reply to: Comments on 'Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening'. International Journal of Cancer. PMID 35377490 DOI: 10.1002/ijc.34013 |
0.575 |
|
| 2022 |
Demarco M, Egemen D, Hyun N, Chen X, Moscicki AB, Cheung L, Carter-Pokras O, Hammer A, Gage JC, Clarke MA, Castle PE, Befano B, Chen J, Dallal C, He X, ... ... Schiffman M, et al. Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test Results. Journal of Lower Genital Tract Disease. PMID 35249974 DOI: 10.1097/LGT.0000000000000667 |
0.604 |
|
| 2022 |
Arbyn M, Castle PE, Schiffman M, Wentzensen N, Heckman-Stoddard B, Sahasrabuddhe VV. Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening. International Journal of Cancer. PMID 35179777 DOI: 10.1002/ijc.33967 |
0.511 |
|
| 2022 |
Mix J, Saraiya M, Hallowell BD, Befano B, Cheung LC, Unger ER, Gargano JW, Markowitz LE, Castle PE, Raine-Bennett T, Walker J, Zuna R, Schiffman M, Wentzensen N, Gage JC. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. Journal of the National Cancer Institute. PMID 35176161 DOI: 10.1093/jnci/djac034 |
0.645 |
|
| 2021 |
Desai KT, Befano B, Xue Z, Kelly H, Campos N, Egemen D, Gage J, Rodriguez AC, Sahasrabuddhe V, Levitz D, Pearlman P, Jeronimo J, Antani S, Schiffman M, de Sanjose S. The development of "Automated Visual Evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing. International Journal of Cancer. PMID 34800038 DOI: 10.1002/ijc.33879 |
0.465 |
|
| 2021 |
Gage JC, Raine-Bennett T, Schiffman M, Clarke MA, Cheung LC, Poitras NE, Varnado NE, Katki HA, Castle PE, Befano B, Chandra M, Rydzak G, Lorey T, Wentzensen N. The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789470 DOI: 10.1158/1055-9965.EPI-21-0865 |
0.572 |
|
| 2021 |
Raine-Bennett T, Gage JC, Poitras N, Chandra M, Varnado N, Befano B, Schiffman M, Lorey T, Wentzensen N. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS). Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 145: 105014. PMID 34768232 DOI: 10.1016/j.jcv.2021.105014 |
0.686 |
|
| 2021 |
Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, Kupets R, Smith R, Arrossi S, Bendahhou K, Canfell K, Chirenje ZM, Chung MH, Del Pino M, de Sanjosé S, ... ... Schiffman M, et al. The IARC Perspective on Cervical Cancer Screening. The New England Journal of Medicine. 385: 1908-1918. PMID 34758259 DOI: 10.1056/NEJMsr2030640 |
0.385 |
|
| 2021 |
Clarke MA, Risley C, Stewart MW, Geisinger KR, Hiser LM, Morgan JC, Owens KJ, Ayyalasomayajula K, Rives RM, Jannela A, Grunes DE, Zhang L, Schiffman M, Wagner S, Boland J, et al. Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi. Cancer Medicine. PMID 34734483 DOI: 10.1002/cam4.4340 |
0.562 |
|
| 2021 |
Pinheiro M, Harari A, Schiffman M, Clifford GM, Chen Z, Yeager M, Cullen M, Boland JF, Raine-Bennett T, Steinberg M, Bass S, Xiao Y, Tenet V, Yu K, Zhu B, et al. Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes. Viruses. 13. PMID 34696378 DOI: 10.3390/v13101948 |
0.655 |
|
| 2021 |
Torres KL, Rondon HHMF, Martins TR, Martins S, Ribeiro A, Raiol T, Marques CP, Corrêa F, Migowski A, Minuzzi-Souza TTCE, Schiffman M, Rodriguez AC, Gage JC. Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city-Lessons learned from the Amazon city of Manaus, Brazil. Plos One. 16: e0258539. PMID 34662368 DOI: 10.1371/journal.pone.0258539 |
0.549 |
|
| 2021 |
Ribeiro A, Corrêa F, Migowski A, Leal A, Martins S, Raiol T, Marques CP, Torres KL, Novetsky AP, Marcus JZ, Wentzensen N, Schiffman M, Rodriguez AC, Gage JC. Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies. Cancer Prevention Research (Philadelphia, Pa.). 14: 919-926. PMID 34607876 DOI: 10.1158/1940-6207.CAPR-21-0110 |
0.439 |
|
| 2021 |
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. 25: 330-331. PMID 34542089 DOI: 10.1097/LGT.0000000000000628 |
0.325 |
|
| 2021 |
Risley C, Stewart MW, Geisinger KR, Hiser LM, Morgan JC, Owens KJ, Ayyalasomayajula K, Rives RM, Jannela A, Grunes DE, Zhang L, Schiffman M, Wentzensen N, Clarke MA. STRIDES - STudying Risk to Improve DisparitiES in Cervical Cancer in Mississippi - Design and baseline results of a Statewide Cohort Study. Preventive Medicine. 106740. PMID 34293382 DOI: 10.1016/j.ypmed.2021.106740 |
0.685 |
|
| 2021 |
Bee KJ, Gradissimo A, Chen Z, Harari A, Schiffman M, Raine-Bennett T, Castle PE, Clarke M, Wentzensen N, Burk RD. Genetic and Epigenetic Variations of HPV52 in Cervical Precancer. International Journal of Molecular Sciences. 22. PMID 34208758 DOI: 10.3390/ijms22126463 |
0.683 |
|
| 2021 |
Pal A, Xue Z, Befano B, Rodriguez AC, Long LR, Schiffman M, Antani S. Deep Metric Learning for Cervical Image Classification. Ieee Access : Practical Innovations, Open Solutions. 9: 53266-53275. PMID 34178558 DOI: 10.1109/access.2021.3069346 |
0.36 |
|
| 2021 |
Campos NG, Demarco M, Bruni L, Desai KT, Gage JC, Adebamowo SN, de Sanjose S, Kim JJ, Schiffman M. A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer. Preventive Medicine. 144: 106438. PMID 33678235 DOI: 10.1016/j.ypmed.2021.106438 |
0.58 |
|
| 2021 |
Perkins RB, Guido RL, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, Feldman S. Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020. Journal of Women's Health (2002). 30: 5-13. PMID 33464997 DOI: 10.1089/jwh.2020.8918 |
0.36 |
|
| 2021 |
Castle PE, Locke A, Tergas AI, Befano B, Poitras N, Shah NR, Schiffman M, Wentzensen N, Strickler HD, Clarke MA, Lorey T. The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses. Gynecologic Oncology. PMID 33454132 DOI: 10.1016/j.ygyno.2021.01.005 |
0.6 |
|
| 2021 |
Schiffman M, Wentzensen N. Cervical Screening Performance. American Journal of Clinical Pathology. PMID 33399187 DOI: 10.1093/ajcp/aqaa198 |
0.402 |
|
| 2020 |
Sierra MS, Tsang SH, Hu S, Porras C, Herrero R, Kreimer AR, Schussler J, Boland J, Wagner S, Cortes B, Rodríguez AC, Quint W, van Doorn LJ, Schiffman M, Sampson JN, et al. Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT). The Journal of Infectious Diseases. PMID 33326576 DOI: 10.1093/infdis/jiaa768 |
0.674 |
|
| 2020 |
Porras C, Tsang SH, Herrero R, Guillén D, Darragh TM, Stoler MH, Hildesheim A, Wagner S, Boland J, Lowy DR, Schiller JT, Schiffman M, Schussler J, Gail MH, Quint W, et al. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. The Lancet. Oncology. 21: 1643-1652. PMID 33271093 DOI: 10.1016/S1470-2045(20)30524-6 |
0.632 |
|
| 2020 |
Goldstein A, Lei Y, Goldstein L, Goldstein A, Bai QX, Felix J, Lipson R, Demarco M, Schiffman M, Egemen D, Desai KT, Bedell S, Gersten J, Goldstein G, O'Keefe K, et al. A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing. Infectious Agents and Cancer. 15: 64. PMID 33106753 DOI: 10.1186/s13027-020-00329-0 |
0.539 |
|
| 2020 |
Ajenifuja KO, Belinson J, Goldstein A, Desai KT, de Sanjose S, Schiffman M. Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2. Infectious Agents and Cancer. 15: 61. PMID 33072179 DOI: 10.1186/s13027-020-00325-4 |
0.642 |
|
| 2020 |
Desai KT, Ajenifuja KO, Banjo A, Adepiti CA, Novetsky A, Sebag C, Einstein MH, Oyinloye T, Litwin TR, Horning M, Olanrewaju FO, Oripelaye MM, Afolabi E, Odujoko OO, Castle PE, ... ... Schiffman M, et al. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage. Infectious Agents and Cancer. 15: 60. PMID 33072178 DOI: 10.1186/s13027-020-00324-5 |
0.593 |
|
| 2020 |
Saraiya M, Cheung L, Soman A, Mix J, Kenney K, Chen X, Perkins RB, Schiffman M, Wentzensen N, Miller J. Risk of Cervical Precancer and Cancer Among Uninsured and Underserved Women 2009-2017. American Journal of Obstetrics and Gynecology. PMID 33035473 DOI: 10.1016/j.ajog.2020.10.001 |
0.336 |
|
| 2020 |
Tota JE, Struyf F, Hildesheim A, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, et al. Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials. The Journal of Infectious Diseases. PMID 32887990 DOI: 10.1093/Infdis/Jiaa561 |
0.659 |
|
| 2020 |
Schiffman M, Wentzensen N. The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening. Journal of the National Cancer Institute. PMID 32745173 DOI: 10.1093/Jnci/Djaa106 |
0.437 |
|
| 2020 |
Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. PMID 32732648 DOI: 10.1097/Lgt.0000000000000562 |
0.433 |
|
| 2020 |
Castle PE, Pierz AJ, Adcock R, Aslam S, Basu PS, Belinson JL, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco EL, Gravitt PE, Isidean SD, Lin J, Mahmud SM, ... ... Schiffman M, et al. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prevention Research (Philadelphia, Pa.). PMID 32655005 DOI: 10.1158/1940-6207.Capr-20-0182 |
0.833 |
|
| 2020 |
Lou H, Boland JF, Torres-Gonzalez E, Albanez A, Zhou W, Steinberg MK, Diaw L, Mitchell J, Roberson D, Cullen M, Garland L, Bass S, Burk RD, Yeager M, Wentzensen N, ... Schiffman M, et al. The D2 and D3 sublineages of human papillomavirus 16-positive cervical cancer in Guatemala differ in integration rate and age of diagnosis. Cancer Research. PMID 32631904 DOI: 10.1158/0008-5472.Can-20-0029 |
0.657 |
|
| 2020 |
Wentzensen N, Lahrmann B, Clarke MA, Kinney W, Tokugawa D, Poitras N, Locke A, Bartels L, Krauthoff A, Walker J, Zuna R, Grewal KK, Goldhoff PE, Kingery JD, Castle PE, ... Schiffman M, et al. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. Journal of the National Cancer Institute. PMID 32584382 DOI: 10.1093/Jnci/Djaa066 |
0.518 |
|
| 2020 |
Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, ... ... Schiffman M, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. Eclinicalmedicine. 22: 100293. PMID 32510043 DOI: 10.1016/J.Eclinm.2020.100293 |
0.749 |
|
| 2020 |
Pinheiro M, Gage JC, Clifford GM, Demarco M, Cheung LC, Chen Z, Yeager M, Cullen M, Boland JF, Chen X, Raine-Bennett T, Steinberg M, Bass S, Befano B, Xiao Y, ... ... Schiffman M, et al. Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention. International Journal of Cancer. PMID 32363580 DOI: 10.1002/Ijc.33033 |
0.76 |
|
| 2020 |
Xue Z, Novetsky AP, Einstein MH, Marcus JZ, Befano B, Guo P, Demarco M, Wentzensen N, Long LR, Schiffman M, Antani S. A demonstration of automated visual evaluation (AVE) of cervical images taken with a smartphone camera. International Journal of Cancer. PMID 32356305 DOI: 10.1002/Ijc.33029 |
0.373 |
|
| 2020 |
Risley C, Clarke MA, Geisinger KR, Stewart MW, Zhang L, Hoover KW, Hiser LM, Owens K, DeMarco M, Schiffman M, Wentzensen N. Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix. Cancer Cytopathology. PMID 32243726 DOI: 10.1002/Cncy.22267 |
0.731 |
|
| 2020 |
Clarke MA, Massad LS, Khan MJ, Smith KM, Guido RS, Mayeaux EJ, Darragh TM, Huh WK, Johnson AL, Gold MA, Schiffman M, Wentzensen N. Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider Perspective. Journal of Lower Genital Tract Disease. 24: 184-191. PMID 32243314 DOI: 10.1097/Lgt.0000000000000506 |
0.506 |
|
| 2020 |
Demarco M, Egemen D, Raine-Bennett TR, Cheung LC, Befano B, Poitras NE, Lorey TS, Chen X, Gage JC, Castle PE, Wentzensen N, Perkins RB, Guido RS, Schiffman M. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease. 24: 144-147. PMID 32243309 DOI: 10.1097/Lgt.0000000000000530 |
0.679 |
|
| 2020 |
Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, ... Schiffman M, et al. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease. 24: 132-143. PMID 32243308 DOI: 10.1097/Lgt.0000000000000529 |
0.454 |
|
| 2020 |
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. 24: 102-131. PMID 32243307 DOI: 10.1097/Lgt.0000000000000525 |
0.436 |
|
| 2020 |
Cheung LC, Egemen D, Chen X, Katki HA, Demarco M, Wiser AL, Perkins RB, Guido RS, Wentzensen N, Schiffman M. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation. Journal of Lower Genital Tract Disease. 24: 90-101. PMID 32243306 DOI: 10.1097/Lgt.0000000000000528 |
0.351 |
|
| 2020 |
Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD. Cervicovaginal microbiome and natural history of HPV in a longitudinal study. Plos Pathogens. 16: e1008376. PMID 32214382 DOI: 10.1371/Journal.Ppat.1008376 |
0.851 |
|
| 2020 |
Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M. Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California. International Journal of Cancer. PMID 32141607 DOI: 10.1002/Ijc.32950 |
0.828 |
|
| 2020 |
Lou H, Gharzouzi E, Guerra SP, Fokom Domgue J, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, ... ... Schiffman M, et al. Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala. Bmc Cancer. 20: 164. PMID 32111179 DOI: 10.1186/S12885-020-6672-3 |
0.566 |
|
| 2020 |
Stratton P, Battiwalla M, Tian X, Abdelazim S, Baird K, Barrett AJ, Cantilena CR, Childs RW, DeJesus J, Fitzhugh C, Fowler D, Gea-Banacloche J, Gress RE, Hickstein D, Hsieh M, ... ... Schiffman M, et al. Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. Jama Oncology. PMID 32105293 DOI: 10.1001/Jamaoncol.2019.6722 |
0.502 |
|
| 2020 |
Tsang SH, Sampson JN, Schussler J, Porras C, Wagner S, Boland J, Cortes B, Lowy DR, Schiller JT, Schiffman M, Kemp TJ, Rodriguez AC, Quint W, Gail MH, Pinto LA, et al. Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial. Journal of the National Cancer Institute. PMID 32091596 DOI: 10.1093/Jnci/Djaa010 |
0.608 |
|
| 2020 |
Kreimer AR, Sampson JN, Porras C, Schiller JT, Kemp T, Herrero R, Wagner S, Boland J, Schussler J, Lowy DR, Chanock S, Roberson D, Sierra MS, Tsang SH, Schiffman M, et al. Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial. Journal of the National Cancer Institute. PMID 32091594 DOI: 10.1093/Jnci/Djaa011 |
0.62 |
|
| 2020 |
Zhu B, Xiao Y, Yeager M, Clifford G, Wentzensen N, Cullen M, Boland JF, Bass S, Steinberg MK, Raine-Bennett T, Lee D, Burk RD, Pinheiro M, Song L, Dean M, ... ... Schiffman M, et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nature Communications. 11: 886. PMID 32060290 DOI: 10.1038/S41467-020-14730-1 |
0.636 |
|
| 2020 |
Venetianer R, Clarke MA, van der Marel J, Tota J, Schiffman M, Dunn ST, Walker J, Zuna R, Quint W, Wentzensen N. Identification of HPV Genotypes Causing Cervical Pre-Cancer using Tissue-Based Genotyping. International Journal of Cancer. PMID 32037535 DOI: 10.1002/Ijc.32919 |
0.707 |
|
| 2019 |
Castle PE, Adcock R, Cuzick J, Wentzensen N, Torrez-Martinez NE, Torres SM, Stoler MH, Ronnett BM, Joste NE, Darragh TM, Gravitt PE, Schiffman M, Hunt WC, Kinney WK, Wheeler CM, et al. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology. Archives of Pathology & Laboratory Medicine. PMID 31718233 DOI: 10.5858/Arpa.2019-0241-Oa |
0.647 |
|
| 2019 |
Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, et al. Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials. Journal of the National Cancer Institute. PMID 31697384 DOI: 10.1093/Jnci/Djz222 |
0.699 |
|
| 2019 |
Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, ... ... Schiffman M, et al. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. The Journal of Infectious Diseases. PMID 31536132 DOI: 10.1093/Infdis/Jiz324 |
0.658 |
|
| 2019 |
Dawson ET, Wagner S, Roberson D, Yeager M, Boland J, Garrison E, Chanock S, Schiffman M, Raine-Bennett T, Lorey T, Castle PE, Mirabello L, Durbin R. Viral coinfection analysis using a MinHash toolkit. Bmc Bioinformatics. 20: 389. PMID 31299914 DOI: 10.1186/S12859-019-2918-Y |
0.639 |
|
| 2019 |
Xi LF, Schiffman M, Hughes JP, Galloway DA, Koutsky LA, Kiviat NB. Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31101617 DOI: 10.1158/1055-9965.Epi-18-0802 |
0.642 |
|
| 2019 |
Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. Jama Internal Medicine. PMID 31081870 DOI: 10.1001/Jamainternmed.2019.0306 |
0.68 |
|
| 2019 |
Schiffman M, de Sanjose S. False positive cervical HPV screening test results. Papillomavirus Research (Amsterdam, Netherlands). PMID 31029852 DOI: 10.1016/J.Pvr.2019.04.012 |
0.733 |
|
| 2019 |
Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE. Absolute risks of cervical precancer among women who fulfil exiting guidelines based on HPV and cytology cotesting. International Journal of Cancer. PMID 30861114 DOI: 10.1002/Ijc.32268 |
0.605 |
|
| 2019 |
Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Schiffman M, Wentzensen N. Development of the TypeSeq Assay for Detection of 51 HPV Genotypes by Next Generation Sequencing. Journal of Clinical Microbiology. PMID 30814267 DOI: 10.1128/Jcm.01794-18 |
0.696 |
|
| 2019 |
Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, ... ... Schiffman M, et al. Human Papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Research (Amsterdam, Netherlands). PMID 30738204 DOI: 10.1016/J.Pvr.2019.02.001 |
0.689 |
|
| 2019 |
Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, Gachuhi N, Wilson B, Jaiswal MS, Befano B, Long LR, Herrero R, Einstein MH, Burk RD, Demarco M, ... ... Schiffman M, et al. An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. Journal of the National Cancer Institute. PMID 30629194 DOI: 10.1097/Ogx.0000000000000687 |
0.486 |
|
| 2019 |
Liu AH, Schiffman M, Gage JC, Castle PE, Wentzensen N. Evaluation of Risk-based Colposcopy for Cervical Precancers Detection in the ASCUS LSIL Triage Study [40B] Obstetrics & Gynecology. 133. DOI: 10.1097/01.Aog.0000559421.25431.08 |
0.484 |
|
| 2018 |
Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results. Journal of the National Cancer Institute. PMID 30576462 DOI: 10.1093/Jnci/Djy192 |
0.637 |
|
| 2018 |
Chen Z, DeSalle R, Schiffman M, Herrero R, Wood CE, Ruiz JC, Clifford GM, Chan PKS, Burk RD. Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans. Plos Pathogens. 14: e1007352. PMID 30383862 DOI: 10.1371/Journal.Ppat.1007352 |
0.652 |
|
| 2018 |
Conrad RD, Liu AH, Wentzensen N, Zhang RR, Dunn ST, Wang SS, Schiffman M, Gold MA, Walker JL, Zuna RE. Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathology. PMID 30351473 DOI: 10.1002/Cncy.22055 |
0.523 |
|
| 2018 |
Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women. Jama Oncology. PMID 30325982 DOI: 10.1001/Jamaoncol.2018.4270 |
0.746 |
|
| 2018 |
Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, Wentzensen N, Strickler HD, Burger EA, Schiffman M. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Preventive Medicine. PMID 30316878 DOI: 10.1016/J.Ypmed.2018.10.001 |
0.646 |
|
| 2018 |
Perkins RB, Schiffman M, Guido RS. The next generation of cervical cancer screening programs: Making the case for risk-based guidelines. Current Problems in Cancer. PMID 30146347 DOI: 10.1016/J.Currproblcancer.2018.06.007 |
0.435 |
|
| 2018 |
Schiffman M, Huh WK, Stockdale CK, Einstein MH, Chelmow D, Flowers LC. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections. Obstetrics and Gynecology. 132: 778-779. PMID 30134395 DOI: 10.1097/AOG.0000000000002828 |
0.358 |
|
| 2018 |
Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N. Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstetrics and Gynecology. PMID 30095780 DOI: 10.1097/Aog.0000000000002812 |
0.642 |
|
| 2018 |
Gravitt PE, Landy R, Schiffman M. How confident can we be in the current guidelines for exiting cervical screening? Preventive Medicine. PMID 29981791 DOI: 10.1016/J.Ypmed.2018.07.005 |
0.717 |
|
| 2018 |
Silkensen SL, Schiffman M, Sahasrabuddhe V, Flanigan JS. Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening? Global Health, Science and Practice. 6: 242-246. PMID 29959268 DOI: 10.9745/Ghsp-D-18-00206 |
0.41 |
|
| 2018 |
Lou H, Gharzouzi E, Guerra SP, Domgue JF, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, ... ... Schiffman M, et al. Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala. Bmc Cancer. 18: 562. PMID 29764400 DOI: 10.1186/S12885-018-4438-Y |
0.762 |
|
| 2018 |
Safaeian M, Castellsagué X, Hildesheim A, Wacholder S, Schiffman MH, Bozonnat MC, Baril L, Rosillon D. Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials. The Journal of Infectious Diseases. PMID 29718393 DOI: 10.1093/Infdis/Jiy112 |
0.824 |
|
| 2018 |
Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M. Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology. Journal of the National Cancer Institute. PMID 29659930 DOI: 10.1093/Jnci/Djy044 |
0.755 |
|
| 2018 |
Demarco M, Cheung LC, Kinney WK, Wentzensen N, Lorey TS, Fetterman B, Poitras NE, Befano B, Castle PE, Schiffman M. Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy. Journal of Lower Genital Tract Disease. 22: 97-103. PMID 29570564 DOI: 10.1097/Lgt.0000000000000382 |
0.52 |
|
| 2018 |
Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M. Validation of an HPV DNA cervical screening test that provides expanded HPV typing. Journal of Clinical Microbiology. PMID 29491018 DOI: 10.1128/Jcm.01910-17 |
0.707 |
|
| 2018 |
Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. American Journal of Obstetrics and Gynecology. PMID 29462629 DOI: 10.1016/J.Ajog.2018.02.009 |
0.666 |
|
| 2018 |
Katki HA, Schiffman M. A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations. Preventive Medicine. PMID 29454079 DOI: 10.1016/J.Ypmed.2018.02.013 |
0.402 |
|
| 2018 |
Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, Cullen M, Boland JF, Schiffman M, Burk RD. The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses. 10. PMID 29438321 DOI: 10.3390/V10020080 |
0.726 |
|
| 2018 |
Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE. Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years. Cancer Prevention Research (Philadelphia, Pa.). PMID 29437696 DOI: 10.1158/1940-6207.Capr-17-0293 |
0.606 |
|
| 2018 |
Clarke MA, Gradíssimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras NE, Raine-Bennett T, Castle PE, Wentzensen N, Burk RD. Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29420222 DOI: 10.1158/1078-0432.Ccr-17-3251 |
0.735 |
|
| 2018 |
Lang Kuhs KA, Lin SW, Hua X, Schiffman M, Burk RD, Rodriguez AC, Herrero R, Abnet CC, Freedman ND, Pinto LA, Hamm D, Robins H, Hildesheim A, Shi J, Safaeian M. T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study. Plos One. 13: e0178167. PMID 29385144 DOI: 10.1371/Journal.Pone.0178167 |
0.847 |
|
| 2018 |
Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, et al. Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. PMID 29366703 DOI: 10.1016/J.Vaccine.2017.12.078 |
0.759 |
|
| 2018 |
Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M. Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017753442. PMID 29356609 DOI: 10.1200/Jco.2017.75.3442 |
0.523 |
|
| 2018 |
Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 516: 86-101. PMID 29331867 DOI: 10.1016/J.Virol.2018.01.002 |
0.79 |
|
| 2018 |
Wentzensen N, Schiffman M. Accelerating cervical cancer control and prevention. The Lancet. Public Health. 3: e6-e7. PMID 29307389 DOI: 10.1016/S2468-2667(17)30242-6 |
0.478 |
|
| 2018 |
Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, et al. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. Journal of the National Cancer Institute. 110. PMID 28954299 DOI: 10.1093/Jnci/Djx158 |
0.784 |
|
| 2018 |
Clarke MA, Fetterman B, Schiffman M, Castle PE, Stiemerling E, Tokugawa D, Poitras N, Kinney W, Lorey T, Wentzensen N. Abstract 2202: Long term risk prediction of p16/Ki-67 dual stain in triage of HPV-positive women Cancer Research. 78: 2202-2202. DOI: 10.1158/1538-7445.Am2018-2202 |
0.668 |
|
| 2017 |
Hyun N, Cheung LC, Pan Q, Schiffman M, Katki HA. FLEXIBLE RISK PREDICTION MODELS FOR LEFT OR INTERVAL-CENSORED DATA FROM ELECTRONIC HEALTH RECORDS. The Annals of Applied Statistics. 11: 1063-1084. PMID 31223347 DOI: 10.1214/17-Aoas1036 |
0.594 |
|
| 2017 |
Conrad R, Wentzensen N, Zhang RR, Wang S, Schiffman M, Gold M, Walker J, Zuna RE. Distribution of cell types differs in Papanicolaou tests of squamous cell carcinomas and adenocarcinomas. Journal of the American Society of Cytopathology. 6: 10-15. PMID 31042628 DOI: 10.1016/J.Jasc.2016.08.003 |
0.423 |
|
| 2017 |
Rendle KA, Schiffman M, Cheung LC, Kinney WK, Fetterman B, Poitras NE, Lorey T, Castle PE. Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting. Preventive Medicine. PMID 29288782 DOI: 10.1016/J.Ypmed.2017.12.023 |
0.481 |
|
| 2017 |
Landy R, Cheung LC, Schiffman M, Gage JC, Hyun N, Wentzensen N, Kinney WK, Castle PE, Fetterman B, Poitras NE, Lorey T, Sasieni PD, Katki HA. Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records. Preventive Medicine. PMID 29222045 DOI: 10.1016/J.Ypmed.2017.12.004 |
0.36 |
|
| 2017 |
Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study. Annals of Internal Medicine. PMID 29181509 DOI: 10.7326/M17-1609 |
0.596 |
|
| 2017 |
Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening. Journal of the National Cancer Institute. PMID 29145648 DOI: 10.1093/Jnci/Djx225 |
0.721 |
|
| 2017 |
Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstetrics and Gynecology. PMID 29112672 DOI: 10.1097/Aog.0000000000002330 |
0.652 |
|
| 2017 |
Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N. Smoking and subsequent human papillomavirus infection: a mediation analysis. Annals of Epidemiology. PMID 29107447 DOI: 10.1016/J.Annepidem.2017.10.004 |
0.768 |
|
| 2017 |
Schiffman M, Wentzensen N. Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions. Preventive Medicine. 105: 378-380. PMID 29056320 DOI: 10.1016/J.Ypmed.2017.09.010 |
0.652 |
|
| 2017 |
Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, Kinney WK, Poitras NE, Befano B, Castle PE, Schiffman M. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. Journal of Lower Genital Tract Disease. 21: 261-267. PMID 28953116 DOI: 10.1097/Lgt.0000000000000343 |
0.626 |
|
| 2017 |
Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, Huh WK, Wentzensen N, Massad LS, Khan MJ, Mayeaux EJ, Einstein MH, Schiffman MH, Guido RS. ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards. Journal of Lower Genital Tract Disease. 21: 235-241. PMID 28953112 DOI: 10.1097/LGT.0000000000000336 |
0.338 |
|
| 2017 |
Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, Mayeaux EJ, Waxman AG, Huh WK, Massad LS. ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. Journal of Lower Genital Tract Disease. 21: 230-234. PMID 28953111 DOI: 10.1097/Lgt.0000000000000334 |
0.511 |
|
| 2017 |
Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ, Waxman AG, Conageski C, Einstein MH, Huh WK. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. Journal of Lower Genital Tract Disease. 21: 223-229. PMID 28953110 DOI: 10.1097/Lgt.0000000000000338 |
0.459 |
|
| 2017 |
Wentzensen N, Massad LS, Mayeaux EJ, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, et al. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. Journal of Lower Genital Tract Disease. 21: 216-222. PMID 28953109 DOI: 10.1097/LGT.0000000000000322 |
0.356 |
|
| 2017 |
Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, ... ... Schiffman M, et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 170: 1164-1174.e6. PMID 28886384 DOI: 10.1016/J.Cell.2017.08.001 |
0.737 |
|
| 2017 |
Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA. Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records. Statistics in Medicine. PMID 28660629 DOI: 10.1002/Sim.7380 |
0.315 |
|
| 2017 |
Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M. Why does cervical cancer occur in a state-of-the-art screening program? Gynecologic Oncology. PMID 28606721 DOI: 10.1016/J.Ygyno.2017.06.003 |
0.61 |
|
| 2017 |
Schiffman M. In response to: Human papillomavirus screening for low and middle-income countries. Preventive Medicine. 100: 297-298. PMID 28583663 DOI: 10.1016/J.Ypmed.2017.04.029 |
0.384 |
|
| 2017 |
Fokom Domgue J, Schiffman M, Wentzensen NH, Gage JC, Castle PE, Raine-Bennett TR, Fetterman B, Lorey T, Poitras NE, Befano B, Xie Y, Miachon LS, Dean M. Assessment of a new lower-cost real-time PCR detection assay for high-risk HPV: Useful for cervical screening in limited resource settings? Journal of Clinical Microbiology. PMID 28515214 DOI: 10.1128/Jcm.00492-17 |
0.702 |
|
| 2017 |
Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, Miller A, Schiffman M, Wentzensen N. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. International Journal of Cancer. PMID 28500655 DOI: 10.1002/Ijc.30781 |
0.634 |
|
| 2017 |
Schiffman M. Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice. Preventive Medicine. 98: 3-4. PMID 28279258 DOI: 10.1016/J.Ypmed.2016.12.028 |
0.737 |
|
| 2017 |
Schiffman M, Wentzensen N, Khan MJ, Castle PE, Chelmow D, Huh WK, Moscicki AB, Stockdale CK, Darragh TM, Silver M, Guido RS. Preparing for the Next Round of ASCCP-Sponsored Cervical Screening and Management Guidelines. Journal of Lower Genital Tract Disease. PMID 28244885 DOI: 10.1097/Lgt.0000000000000300 |
0.445 |
|
| 2017 |
Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WA, Porras C, Quint W, ... ... Schiffman M, et al. Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials. Journal of the National Cancer Institute. 109. PMID 28132019 DOI: 10.1093/Jnci/Djw300 |
0.652 |
|
| 2017 |
Rodríguez AC, Ávila C, Herrero R, Hildesheim A, Sherman ME, Burk RD, Morales J, Alfaro M, Guillén D, Trejos ME, Vargas RM, Torres G, Schiffman M. Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort. International Journal of Cancer. PMID 28120391 DOI: 10.1002/Ijc.30614 |
0.712 |
|
| 2017 |
Xi LF, Schiffman M, Ke Y, Hughes JP, Galloway DA, He Z, Hulbert A, Winer RL, Koutsky LA, Kiviat NB. Type-Dependent Association between Risk of Cervical Intraepithelial Neoplasia and Viral Load of Oncogenic Human Papillomavirus Types Other than Types 16 and 18. International Journal of Cancer. PMID 28052328 DOI: 10.1002/Ijc.30594 |
0.733 |
|
| 2017 |
Schiffman M, Saraiya M. Control of HPV-associated cancers with HPV vaccination. The Lancet. Infectious Diseases. 17: 6-8. PMID 27282423 DOI: 10.1016/S1473-3099(16)30146-3 |
0.707 |
|
| 2017 |
Demarco M, Hyun N, Katki H, Befano B, Cheung L, Raine-Bennett TR, Fetterman B, Lorey T, Poitras N, Gage JC, Castle PE, Wentzensen N, Schiffman M. Abstract A28: Risk model for clinical management of HPV-infected women Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-A28 |
0.741 |
|
| 2017 |
Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA. Abstract 5300: Risk models for cancer screening cohorts assembled from electronic health records: Application to calculating risks that underlie current cervical cancer screening guidelines Epidemiology. 77: 5300-5300. DOI: 10.1158/1538-7445.Am2017-5300 |
0.389 |
|
| 2017 |
Wentzensen NA, Fetterman B, Bremer R, Castle P, Tokugawa D, Poitras N, Hosfield E, Lorey T, Schiffman M, Kinney W. Abstract 5296: Evaluation of p16/Ki-67 dual stain, cytology, and HPV16/18 genotyping for triage of HPV-positive women in a large screening population Cancer Research. 77: 5296-5296. DOI: 10.1158/1538-7445.Am2017-5296 |
0.758 |
|
| 2017 |
Xiao Y, Zhu B, Yeager M, Cullen M, Boland J, Wentzensen N, Raine-Bennett T, Chen Z, Yu K, Yang Q, Steinberg M, Roberson D, Bass S, Burdette L, Lorey T, ... ... Schiffman M, et al. Abstract 4249: Evidence of APOBEC3 editing in the HPV16 genome Epidemiology. 77: 4249-4249. DOI: 10.1158/1538-7445.Am2017-4249 |
0.656 |
|
| 2016 |
Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nature Reviews. Disease Primers. 2: 16086. PMID 27905473 DOI: 10.1038/nrdp.2016.86 |
0.707 |
|
| 2016 |
Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS. Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecologic Oncology. PMID 27894752 DOI: 10.1016/J.Ygyno.2016.11.031 |
0.478 |
|
| 2016 |
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstetrics and Gynecology. PMID 27824767 DOI: 10.1097/Aog.0000000000001721 |
0.521 |
|
| 2016 |
Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N. Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2. International Journal of Cancer. PMID 27696414 DOI: 10.1002/Ijc.30456 |
0.724 |
|
| 2016 |
Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen. Cancer. PMID 27657992 DOI: 10.1002/Cncr.30277 |
0.683 |
|
| 2016 |
Schiffman M, Hyun N, Raine-Bennett TR, Katki H, Fetterman B, Gage JC, Cheung LC, Befano B, Poitras N, Lorey T, Castle PE, Wentzensen NH. A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage. International Journal of Cancer. PMID 27509172 DOI: 10.1002/Ijc.30375 |
0.734 |
|
| 2016 |
Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, et al. Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27507769 DOI: 10.1158/1055-9965.Epi-16-0555 |
0.325 |
|
| 2016 |
Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. Corrigendum to "A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry" [HumAN PatholOGY 2013;44:2542-2548]. Human Pathology. PMID 27141825 DOI: 10.1016/J.Humpath.2016.04.001 |
0.403 |
|
| 2016 |
Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, Zhang X, Yu K, Yang Q, Mitchell J, Roberson D, Bass S, Xiao Y, Burdett L, Raine-Bennett T, ... ... Schiffman M, et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. Journal of the National Cancer Institute. 108. PMID 27130930 DOI: 10.1093/Jnci/Djw100 |
0.727 |
|
| 2016 |
Xi LF, Schiffman M, Koutsky LA, Hughes JP, Hulbert A, Shen Z, Galloway DA, Kiviat NB. Variant-Specific Persistence of Infections with Human Papillomavirus Types 31, 33, 45, 56 and 58 and Risk of Cervical Intraepithelial Neoplasia. International Journal of Cancer. PMID 27121353 DOI: 10.1002/Ijc.30164 |
0.669 |
|
| 2016 |
Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R. Impact of Human Papillomavirus (HPV) 16 and 18 Vaccination on Prevalent Infections and Rates of Cervical Lesions After Excisional Treatment. American Journal of Obstetrics and Gynecology. PMID 26892991 DOI: 10.1016/J.Ajog.2016.02.021 |
0.612 |
|
| 2016 |
Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M. Risk assessment to guide cervical screening strategies in a large chinese population. International Journal of Cancer. Journal International Du Cancer. PMID 26800481 DOI: 10.1002/Ijc.30012 |
0.692 |
|
| 2016 |
Schiffman M, Wentzensen N. A Suggested Approach to Simplify and Improve Cervical Screening in the United States. Journal of Lower Genital Tract Disease. 20: 1-7. PMID 26704326 DOI: 10.1097/Lgt.0000000000000170 |
0.749 |
|
| 2016 |
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, et al. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. Journal of the National Cancer Institute. 108. PMID 26467666 DOI: 10.1093/Jnci/Djv302 |
0.817 |
|
| 2016 |
Liu AH, Schiffman M, Gage JC, Castle PE, Wentzensen N. Abstract 2586: Evaluation of risk-based colposcopy in the ALTS trial Cancer Research. 76: 2586-2586. DOI: 10.1158/1538-7445.Am2016-2586 |
0.627 |
|
| 2016 |
Rendle KA, Schiffman M, Cheung LC, Kinney WK, Fetterman B, Poitras NE, Castle PE. Abstract 2579: Longitudinal predictors of adherence to cervical cancer cotesting guidelines Cancer Research. 76: 2579-2579. DOI: 10.1158/1538-7445.Am2016-2579 |
0.565 |
|
| 2016 |
Schiffman M, Wentzensen N. A Suggested Approach to Simplify and Improve Cervical Screening in the United States Journal of Lower Genital Tract Disease. 20: 1-7. DOI: 10.1097/LGT.0000000000000170 |
0.703 |
|
| 2015 |
Bodelon C, Vinokourova S, Sampson JN, den Boon JA, Walker JL, Horswill MA, Korthauer K, Schiffman M, Sherman ME, Zuna RE, Mitchell J, Zhang X, Boland JF, Chaturvedi AK, Dunn T, et al. Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. Carcinogenesis. PMID 26660085 DOI: 10.1093/Carcin/Bgv171 |
0.659 |
|
| 2015 |
Cullen M, Boland JF, Schiffman M, Zhang X, Wentzensen N, Yang Q, Chen Z, Yu K, Mitchell J, Roberson D, Bass S, Burdette L, Machado M, Ravichandran S, Luke B, et al. Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Research. 1: 3-11. PMID 26645052 DOI: 10.1016/J.Pvr.2015.05.004 |
0.712 |
|
| 2015 |
Wentzensen N, Schiffman M, Palmer T, Arbyn M. Triage of HPV positive women in cervical cancer screening. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. PMID 26643050 DOI: 10.1016/J.Jcv.2015.11.015 |
0.718 |
|
| 2015 |
Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, et al. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. Bmc Infectious Diseases. 15: 544. PMID 26607224 DOI: 10.1186/S12879-015-1281-5 |
0.676 |
|
| 2015 |
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, Group Author NM. Risk Stratification using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-wide Surveillance Program. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26518316 DOI: 10.1158/1055-9965.Epi-15-0669 |
0.652 |
|
| 2015 |
Harari A, Chen Z, Rodríguez AC, Hildesheim A, Porras C, Herrero R, Wacholder S, Panagiotou OA, Befano B, Burk RD, Schiffman M. Cross-protection of the bivalent human papillomavirus (HPV) vaccine against variants of genetically related high-risk HPV infections. The Journal of Infectious Diseases. PMID 26518044 DOI: 10.1093/Infdis/Jiv519 |
0.722 |
|
| 2015 |
Schiffman M, Wentzensen N. Towards therapeutic vaccination against cervical precancer? The Lancet. 386: 2036-2038. PMID 26386539 DOI: 10.1016/S0140-6736(15)00240-8 |
0.486 |
|
| 2015 |
Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Poitras N, Lorey T, Kinney W. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. Journal of the National Cancer Institute. 107. PMID 26376685 DOI: 10.1093/jnci/djv257 |
0.699 |
|
| 2015 |
Panagiotou OA, Befano BL, Gonzalez P, Rodríguez AC, Herrero R, Schiller JT, Kreimer AR, Schiffman M, Hildesheim A, Wilcox AJ, Wacholder S. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. Bmj (Clinical Research Ed.). 351: h4358. PMID 26346155 DOI: 10.1136/Bmj.H4358 |
0.487 |
|
| 2015 |
Liu X, Schiffman M, Hulbert A, He Z, Shen Z, Koutsky LA, Xi LF. Association of Human Papillomavirus Type 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2-3. Journal of Clinical Microbiology. PMID 26292291 DOI: 10.1128/Jcm.01279-15 |
0.713 |
|
| 2015 |
Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecologic Oncology. 138: 573-8. PMID 26148763 DOI: 10.1016/J.Ygyno.2015.06.040 |
0.753 |
|
| 2015 |
Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1304-10. PMID 26088703 DOI: 10.1158/1055-9965.Epi-14-1353 |
0.749 |
|
| 2015 |
van der Marel J, Rodriguez A, Del Pino M, van Baars R, Jenkins D, van de Sandt MM, Torné A, Ordi J, Ter Harmsel B, Verheijen RH, Schiffman M, Gage JC, Quint WG, Wentzensen N. The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy. Journal of Lower Genital Tract Disease. PMID 26083332 DOI: 10.1097/Lgt.0000000000000124 |
0.492 |
|
| 2015 |
den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, Schott M, Chung L, He Q, Lambert P, Walker J, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 112: E3255-64. PMID 26056290 DOI: 10.1073/Pnas.1509322112 |
0.56 |
|
| 2015 |
Frimer M, Sun C, McAndrew T, Smith B, Harari A, Chen Z, Mirabello L, Wentzensen N, Goldberg GL, Rodriguez AC, Schiffman M, Burk RD. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study. Gynecologic Oncology. 138: 94-100. PMID 26001326 DOI: 10.1016/J.Ygyno.2015.05.001 |
0.602 |
|
| 2015 |
Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era. Ecancermedicalscience. 9: 530. PMID 25987899 DOI: 10.3332/Ecancer.2015.530 |
0.653 |
|
| 2015 |
Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, et al. Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine. 33: 2141-51. PMID 25796338 DOI: 10.1016/J.Vaccine.2015.03.015 |
0.814 |
|
| 2015 |
Schiffman M, Wentzensen N. Transitioning to a new era in cervical cancer screening Gynecologic Oncology. 136: 175-177. PMID 25680631 DOI: 10.1016/J.Ygyno.2015.01.538 |
0.447 |
|
| 2015 |
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Gynecologic Oncology. 136: 178-182. PMID 25579107 DOI: 10.1016/J.Ygyno.2014.12.022 |
0.474 |
|
| 2015 |
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Journal of Lower Genital Tract Disease. 19: 91-6. PMID 25574659 DOI: 10.1097/Lgt.0000000000000103 |
0.519 |
|
| 2015 |
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstetrics and Gynecology. 125: 330-7. PMID 25569009 DOI: 10.1097/Aog.0000000000000669 |
0.483 |
|
| 2015 |
Porras C, Hildesheim A, González P, Schiffman M, Rodríguez AC, Wacholder S, Jiménez S, Quint W, Guillen D, Kreimer AR, Herrero R. Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing. Journal of the National Cancer Institute. 107: 400. PMID 25479804 DOI: 10.1093/Jnci/Dju400 |
0.594 |
|
| 2015 |
Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, Tenney M, Nugent E, Graubard BI, Wacholder S, Schiffman M. Multiple biopsies and detection of cervical cancer precursors at colposcopy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 83-9. PMID 25422481 DOI: 10.1200/Jco.2014.55.9948 |
0.536 |
|
| 2015 |
van der Marel J, Berkhof J, Ordi J, Torné A, Del Pino M, van Baars R, Schiffman M, Wentzensen N, Jenkins D, Quint WG. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion? The American Journal of Surgical Pathology. 39: 496-504. PMID 25353286 DOI: 10.1097/Pas.0000000000000342 |
0.699 |
|
| 2015 |
Gage JC, Katki HA, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Castle PE, Kinney WK. Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection. International Journal of Cancer. 136: 1665-71. PMID 25136967 DOI: 10.1002/Ijc.29143 |
0.719 |
|
| 2015 |
Mirabello L, Frimer M, Harari A, McAndrew T, Smith B, Chen Z, Wentzensen N, Wacholder S, Castle PE, Raine-Bennett T, Schiffman M, Burk RD. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. International Journal of Cancer. Journal International Du Cancer. 136: E146-53. PMID 25081507 DOI: 10.1002/Ijc.29119 |
0.598 |
|
| 2015 |
Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N. Abstract 852: Smoking and HPV antibodies, a mediation analysis of HPV re-infection Cancer Research. 75: 852-852. DOI: 10.1158/1538-7445.Am2015-852 |
0.78 |
|
| 2015 |
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Jimenez S, Struijk L, Schussler J, Hildesheim A, Gonzalez P. Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure Cancer Research. 75: 4680-4680. DOI: 10.1158/1538-7445.Am2015-4680 |
0.724 |
|
| 2015 |
Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The role of human papillomavirus genotyping in cervical cancer screening: A large-scale evaluation of the cobas HPV test Cancer Epidemiology Biomarkers and Prevention. 24: 1304-1310. DOI: 10.1158/1055-9965.EPI-14-1353 |
0.628 |
|
| 2015 |
Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results Journal of Clinical Microbiology. 53: 52-59. DOI: 10.1128/JCM.02116-14 |
0.455 |
|
| 2015 |
Castle PE, Zhao FH, Kinney WK, Cheung L, Schiffman M, Fetterman B, Poitras N, Lorey T, Gage J, Wentzensen N, Katki H. Cervical cancer risk following three rounds of human papillomavirus (HPV) and cytology co-testing in a one million-women cohort Gynecologic Oncology. 137: 16-17. DOI: 10.1016/J.Ygyno.2015.01.039 |
0.739 |
|
| 2014 |
Xi LF, Schiffman M, Koutsky LA, Hughes JP, Winer RL, Mao C, Hulbert A, Lee SK, Shen Z, Kiviat NB. Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia. Journal of the National Cancer Institute. 106. PMID 25217779 DOI: 10.1093/Jnci/Dju270 |
0.732 |
|
| 2014 |
van der Marel J, van Baars R, Rodriguez A, Quint WG, van de Sandt MM, Berkhof J, Schiffman M, Torné A, Ordi J, Jenkins D, Verheijen RH, Helmerhorst TJ, Ter Harmsel B, Wentzensen N, Del Pino M. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy. Gynecologic Oncology. 135: 201-7. PMID 25204846 DOI: 10.1016/J.Ygyno.2014.08.040 |
0.586 |
|
| 2014 |
Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, et al. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. American Journal of Epidemiology. 180: 599-607. PMID 25139208 DOI: 10.1093/Aje/Kwu168 |
0.852 |
|
| 2014 |
Wentzensen N, Fetterman B, Tokugawa D, Schiffman M, Castle PE, Wood SN, Stiemerling E, Poitras N, Lorey T, Kinney W. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening Cancer Cytopathology. 122: 914-920. PMID 25132656 DOI: 10.1002/Cncy.21473 |
0.399 |
|
| 2014 |
Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. American Journal of Epidemiology. 180: 545-55. PMID 25081182 DOI: 10.1093/Aje/Kwu159 |
0.664 |
|
| 2014 |
Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Behrens C, Sharma A, Zhao FH, Cuzick J, Yang ZH, Kinney WK. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management. Cancer Cytopathology. 122: 842-50. PMID 25045058 DOI: 10.1002/Cncy.21463 |
0.682 |
|
| 2014 |
Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. Journal of the National Cancer Institute. 106. PMID 25038467 DOI: 10.1093/Jnci/Dju153 |
0.706 |
|
| 2014 |
Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, et al. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial. The Journal of Infectious Diseases. 210: 1890-9. PMID 24958910 DOI: 10.1093/Infdis/Jiu357 |
0.812 |
|
| 2014 |
Zhao L, Wentzensen N, Zhang RR, Dunn ST, Gold MA, Wang SS, Schiffman M, Walker JL, Zuna RE. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathology. 122: 694-701. PMID 24888458 DOI: 10.1002/cncy.21443 |
0.384 |
|
| 2014 |
Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 414-7. PMID 24881489 DOI: 10.1016/J.Jcv.2014.04.016 |
0.799 |
|
| 2014 |
Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, et al. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. Bmc Infectious Diseases. 14: 120. PMID 24588945 DOI: 10.1186/1471-2334-14-120 |
0.813 |
|
| 2014 |
Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. The Journal of Infectious Diseases. 210: 448-55. PMID 24569064 DOI: 10.1093/Infdis/Jiu104 |
0.851 |
|
| 2014 |
Wentzensen N, Schiffman M. Filling a gap in cervical cancer screening programmes The Lancet Oncology. 15: 249-251. PMID 24529698 DOI: 10.1016/S1470-2045(14)70073-7 |
0.708 |
|
| 2014 |
van der Marel J, van Baars R, Quint WG, Berkhof J, del Pino M, Torné A, Ordi J, Wentzensen N, Schiffman M, van de Sandt MM, Lindeman J, Jenkins D, Helmerhorst TJ, Verheijen RH, ter Harmsel B, et al. The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysis. Bjog : An International Journal of Obstetrics and Gynaecology. 121: 1117-26. PMID 24494663 DOI: 10.1111/1471-0528.12668 |
0.694 |
|
| 2014 |
Robbins HA, Kemp TJ, Porras C, Rodriguez AC, Schiffman M, Wacholder S, Gonzalez P, Schiller J, Lowy D, Poncelet S, Esser M, Matys K, Hildesheim A, Pinto LA, Herrero R, et al. Comparison of antibody responses to human papillomavirus vaccination as measured by three assays. Frontiers in Oncology. 3: 328. PMID 24455487 DOI: 10.3389/Fonc.2013.00328 |
0.724 |
|
| 2014 |
Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. Journal of Clinical Microbiology. 52: 187-92. PMID 24197879 DOI: 10.1128/Jcm.01623-13 |
0.823 |
|
| 2014 |
Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM. No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. The Journal of Infectious Diseases. 209: 855-64. PMID 24179110 DOI: 10.1093/Infdis/Jit577 |
0.673 |
|
| 2014 |
Koshiol J, Sklavos M, Wentzensen N, Kemp T, Schiffman M, Dunn ST, Wang SS, Walker JL, Safaeian M, Zuna RE, Hildesheim A, Pfeiffer RM, Pinto LA. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. International Journal of Cancer. Journal International Du Cancer. 134: 411-25. PMID 23824624 DOI: 10.1002/Ijc.28354 |
0.844 |
|
| 2014 |
Kinney WK, Fetterman B, Castle PE, Schiffman M, Poitras N, Wood S, Lorey T, Wentzensen N. Triage of HPV positive women with low grade squamous epithelial lesion (LSIL) cytology by p16/Ki-67 Gynecologic Oncology. 133: 186-187. DOI: 10.1016/J.Ygyno.2014.03.495 |
0.306 |
|
| 2014 |
Katki H, Berg C, Castle P, Chaturvedi A, Schiffman M, Wacholder S. Developing Risk-Based Screening Guidelines: Translational Epidemiology in Action Annals of Epidemiology. 24: 682. DOI: 10.1016/J.Annepidem.2014.06.007 |
0.383 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: H1-31. PMID 24332295 DOI: 10.1016/j.vaccine.2013.10.003 |
0.689 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: G1-31. PMID 24331817 DOI: 10.1016/j.vaccine.2013.10.002 |
0.689 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: F1-31. PMID 24331745 DOI: 10.1016/j.vaccine.2013.10.001 |
0.689 |
|
| 2013 |
Schiffman M, Solomon D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting. The New England Journal of Medicine. 369: 2324-31. PMID 24328466 DOI: 10.1056/Nejmcp1210379 |
0.733 |
|
| 2013 |
Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, ... ... Schiffman M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 31: I1-31. PMID 24229716 DOI: 10.1016/J.Vaccine.2013.07.026 |
0.74 |
|
| 2013 |
Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, Herrero R, Kemp T, Shelton G, Quint W, van Doorn LJ, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 1242-50. PMID 24189371 DOI: 10.1158/1940-6207.Capr-13-0203 |
0.776 |
|
| 2013 |
Gage JC, Joste N, Ronnett BM, Stoler M, Hunt WC, Schiffman M, Wheeler CM. A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry. Human Pathology. 44: 2542-8. PMID 24075599 DOI: 10.1016/J.Humpath.2013.06.015 |
0.581 |
|
| 2013 |
Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. The Journal of Infectious Diseases. 208: 1643-52. PMID 24014882 DOI: 10.1093/Infdis/Jit369 |
0.812 |
|
| 2013 |
Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. Plos One. 8: e72565. PMID 23977318 DOI: 10.1371/Journal.Pone.0072565 |
0.796 |
|
| 2013 |
Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. Plos One. 8: e68329. PMID 23873171 DOI: 10.1371/Journal.Pone.0068329 |
0.695 |
|
| 2013 |
Chang YJ, Chen HC, Pan MH, Lee BH, You SL, Lin CY, Chou YC, Hsieh CY, Cheng YJ, Liaw KL, Hsing AW, Schiffman M, Chen CJ. Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan. Journal of Medical Virology. 85: 1567-76. PMID 23852681 DOI: 10.1002/Jmv.23651 |
0.742 |
|
| 2013 |
RodrÃguez AC, Solomon D, Herrero R, Hildesheim A, González P, Wacholder S, Porras C, Jiménez S, Schiffman M. Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment. American Journal of Epidemiology. 178: 752-60. PMID 23843026 DOI: 10.1093/Aje/Kwt047 |
0.601 |
|
| 2013 |
Clarke M, Schiffman M, Wacholder S, Rodriguez AC, Hildesheim A, Quint W. A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. Bmc Infectious Diseases. 13: 308. PMID 23834901 DOI: 10.1186/1471-2334-13-308 |
0.639 |
|
| 2013 |
Luhn P, Houldsworth J, Cahill L, Schiffman M, Castle PE, Zuna RE, Dunn ST, Gold MA, Walker J, Wentzensen N. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecologic Oncology. 130: 595-600. PMID 23769811 DOI: 10.1016/J.Ygyno.2013.06.005 |
0.459 |
|
| 2013 |
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstetrics and Gynecology. 121: 829-46. PMID 23635684 DOI: 10.1097/AOG.0b013e3182883a34 |
0.471 |
|
| 2013 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1095-101. PMID 23603204 DOI: 10.1158/1055-9965.Epi-12-1455 |
0.833 |
|
| 2013 |
Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. International Journal of Cancer. Journal International Du Cancer. 133: 2172-81. PMID 23588935 DOI: 10.1002/Ijc.28215 |
0.867 |
|
| 2013 |
Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, et al. Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial. Human Vaccines & Immunotherapeutics. 9: 1399-406. PMID 23571174 DOI: 10.4161/Hv.24340 |
0.837 |
|
| 2013 |
Alter BP, Giri N, Savage SA, Quint WG, de Koning MN, Schiffman M. Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. International Journal of Cancer. 133: 1513-5. PMID 23558727 DOI: 10.1002/Ijc.28157 |
0.628 |
|
| 2013 |
Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer Cancer Epidemiology Biomarkers and Prevention. 22: 553-560. PMID 23549399 DOI: 10.1158/1055-9965.Epi-12-1406 |
0.509 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. Journal of Lower Genital Tract Disease. 17: S78-84. PMID 23519309 DOI: 10.1097/Lgt.0B013E31828543C5 |
0.67 |
|
| 2013 |
Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less. Journal of Lower Genital Tract Disease. 17: S69-77. PMID 23519308 DOI: 10.1097/Lgt.0B013E31828543B1 |
0.71 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years. Journal of Lower Genital Tract Disease. 17: S64-8. PMID 23519307 DOI: 10.1097/Lgt.0B013E3182854399 |
0.361 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. Journal of Lower Genital Tract Disease. 17: S56-63. PMID 23519306 DOI: 10.1097/Lgt.0B013E318285437B |
0.737 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results. Journal of Lower Genital Tract Disease. 17: S50-5. PMID 23519305 DOI: 10.1097/Lgt.0B013E3182854282 |
0.744 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. Journal of Lower Genital Tract Disease. 17: S43-9. PMID 23519304 DOI: 10.1097/Lgt.0B013E3182854269 |
0.755 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. Journal of Lower Genital Tract Disease. 17: S36-42. PMID 23519303 DOI: 10.1097/Lgt.0B013E3182854253 |
0.763 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. Journal of Lower Genital Tract Disease. 17: S28-35. PMID 23519302 DOI: 10.1097/Lgt.0B013E318285423C |
0.687 |
|
| 2013 |
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Journal of Lower Genital Tract Disease. 17: S1-S27. PMID 23519301 DOI: 10.1097/Lgt.0B013E318287D329 |
0.558 |
|
| 2013 |
Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM. Cervical histopathology variability among laboratories: a population-based statewide investigation. American Journal of Clinical Pathology. 139: 330-5. PMID 23429369 DOI: 10.1309/Ajcpsd3Zxjxp7Nnb |
0.617 |
|
| 2013 |
Lamere BJ, Castle PE, Fetterman B, Poitras N, Stanley M, Shieh J, Lorey T, Kinney W, Schiffman M. A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retesting. Journal of Virological Methods. 189: 77-9. PMID 23384678 DOI: 10.1016/J.Jviromet.2013.01.011 |
0.721 |
|
| 2013 |
Ajenifuja KO, Gage JC, Adepiti AC, Wentzensen N, Eklund C, Reilly M, Hutchinson M, Burk RD, Schiffman M. A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 507-12. PMID 23354369 DOI: 10.1097/Igc.0B013E318280F395 |
0.449 |
|
| 2013 |
Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, et al. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. Plos One. 8: e53067. PMID 23301022 DOI: 10.1371/Journal.Pone.0053067 |
0.828 |
|
| 2013 |
Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. Journal of the National Cancer Institute. 105: 175-201. PMID 23297039 DOI: 10.1093/Jnci/Djs491 |
0.629 |
|
| 2013 |
Koshiol J, Dunn ST, Walker JL, Zuna RE, Schiffman M, Sherman ME, Gold MA, Allen RA, Zhang R, Wang SS, Wentzensen N. Reproducibility of linear array for human papillomavirus genotyping. Journal of Clinical Microbiology. 51: 625-8. PMID 23196360 DOI: 10.1128/Jcm.03036-12 |
0.563 |
|
| 2013 |
Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, Wang S, Wentzensen N. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecologic Oncology. 128: 265-70. PMID 23146688 DOI: 10.1016/J.Ygyno.2012.11.003 |
0.595 |
|
| 2013 |
Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. International Journal of Cancer. Journal International Du Cancer. 132: 1412-22. PMID 22847263 DOI: 10.1002/Ijc.27750 |
0.633 |
|
| 2013 |
Xi LF, Schiffman M, Koutsky LA, He Z, Winer RL, Hulbert A, Lee SK, Ke Y, Kiviat NB. Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage. International Journal of Cancer. Journal International Du Cancer. 132: 549-55. PMID 22729840 DOI: 10.1002/Ijc.27689 |
0.588 |
|
| 2013 |
Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, Allen RA, Zhang R, Sherman M, Gold MA, Wang SS. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. International Journal of Cancer. Journal International Du Cancer. 132: 148-54. PMID 22488167 DOI: 10.1002/Ijc.27577 |
0.747 |
|
| 2013 |
Frimer M, Harari A, Mirabello L, Chen Z, Wentzensent N, Castle P, Kinney W, Goldberg G, Schiffman M, Burk R. HPV16 methylation is a consistent biomarker of cervical intraepithelial neoplasia (CIN) 3 using a novel next-generation bisulfite-sequencing technology Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.182 |
0.664 |
|
| 2012 |
Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 30: F24-33. PMID 23199964 DOI: 10.1016/J.Vaccine.2012.05.089 |
0.74 |
|
| 2012 |
Franco EL, de Sanjosé S, Broker TR, Stanley MA, Chevarie-Davis M, Isidean SD, Schiffman M. Human papillomavirus and cancer prevention: Gaps in knowledge and prospects for research, policy, and advocacy Vaccine. 30: F175-F182. PMID 23199961 DOI: 10.1016/J.Vaccine.2012.06.092 |
0.704 |
|
| 2012 |
Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. Journal of the National Cancer Institute. 104: 1738-49. PMID 23093560 DOI: 10.1093/Jnci/Djs425 |
0.742 |
|
| 2012 |
Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M, Burk RD. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 2125-37. PMID 23035178 DOI: 10.1158/1055-9965.Epi-12-0905 |
0.712 |
|
| 2012 |
Castle PE, Gravitt PE, Wentzensen N, Schiffman M. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities. American Journal of Clinical Pathology. 138: 241-6. PMID 22904136 DOI: 10.1309/Ajcpntk6G2Pxwhoo |
0.78 |
|
| 2012 |
Castro FA, Quint W, Gonzalez P, Katki HA, Herrero R, van Doorn LJ, Schiffman M, Struijk L, Rodriguez AC, DelVecchio C, Lowy DR, Porras C, Jimenez S, Schiller J, Solomon D, et al. Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. The Journal of Infectious Diseases. 206: 1103-10. PMID 22850119 DOI: 10.1093/Infdis/Jis458 |
0.744 |
|
| 2012 |
Smith BC, McAndrew T, Chen Z, Harari A, Barris DM, Viswanathan S, Rodriguez AC, Castle P, Herrero R, Schiffman M, Burk RD. The cervical microbiome over 7 years and a comparison of methodologies for its characterization. Plos One. 7: e40425. PMID 22792313 DOI: 10.1371/Journal.Pone.0040425 |
0.535 |
|
| 2012 |
Safaeian M, Ghosh A, Porras C, Lin SW, Rodriguez AC, Schiffman M, Wacholder S, Kemp T, Gonzalez P, Wentzensen N, Esser M, Meuree A, Matys K, Quint W, van Doorn LJ, et al. Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1547-54. PMID 22752082 DOI: 10.1158/1055-9965.Epi-12-0558 |
0.846 |
|
| 2012 |
Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4154-62. PMID 22675168 DOI: 10.1158/1078-0432.CCR-12-0270 |
0.614 |
|
| 2012 |
Safaeian M, Hildesheim A, Gonzalez P, Yu K, Porras C, Li Q, Rodriguez AC, Sherman ME, Schiffman M, Wacholder S, Burk R, Herrero R, Burdette L, Chanock SJ, Wang SS. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. Plos One. 7: e33619. PMID 22496757 DOI: 10.1371/Journal.Pone.0033619 |
0.845 |
|
| 2012 |
Gage JC, Ajenifuja KO, Wentzensen N, Adepiti AC, Stoler M, Eder PS, Bell L, Shrestha N, Eklund C, Reilly M, Hutchinson M, Wacholder S, Castle PE, Burk RD, Schiffman M. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. International Journal of Cancer. Journal International Du Cancer. 131: 2903-9. PMID 22473652 DOI: 10.1002/Ijc.27563 |
0.61 |
|
| 2012 |
Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Hildesheim A, Herrero R, Wacholder S, Lorincz A, Burk RD. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. Journal of the National Cancer Institute. 104: 556-65. PMID 22448030 DOI: 10.1093/Jnci/Djs135 |
0.667 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, ... ... Schiffman M, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American Journal of Clinical Pathology. 137: 516-42. PMID 22431528 DOI: 10.1309/Ajcptgd94Evrsjcg |
0.615 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, ... ... Schiffman M, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Ca: a Cancer Journal For Clinicians. 62: 147-72. PMID 22422631 DOI: 10.3322/Caac.21139 |
0.615 |
|
| 2012 |
Van Der Marel J, Quint WGV, Schiffman M, Van De Sandt MM, Zuna RE, Terence Dunn S, Smith K, Mathews CA, Gold MA, Walker J, Wentzensen N. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16 International Journal of Cancer. 131. PMID 22419273 DOI: 10.1002/Ijc.27532 |
0.753 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, ... ... Schiffman M, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Journal of Lower Genital Tract Disease. 16: 175-204. PMID 22418039 DOI: 10.1097/Lgt.0B013E31824Ca9D5 |
0.584 |
|
| 2012 |
Xi LF, Schiffman M, Koutsky LA, Hulbert A, Lee SK, Defilippis V, Shen Z, Kiviat NB. Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3. International Journal of Cancer. Journal International Du Cancer. 131: 2300-7. PMID 22396129 DOI: 10.1002/Ijc.27520 |
0.751 |
|
| 2012 |
Wentzensen N, Gravitt PE, Long R, Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE, Sherman ME, Gold MA, Walker JL, Wang SS. Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. Journal of Clinical Microbiology. 50: 1564-70. PMID 22337992 DOI: 10.1128/Jcm.06240-11 |
0.802 |
|
| 2012 |
Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, Burk R, Schiffman M. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. Bmc Infectious Diseases. 12: 33. PMID 22316377 DOI: 10.1186/1471-2334-12-33 |
0.61 |
|
| 2012 |
Yang HP, Zuna RE, Schiffman M, Walker JL, Sherman ME, Landrum LM, Moxley K, Gold MA, Dunn ST, Allen RA, Zhang R, Long R, Wang SS, Wentzensen N. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. Plos One. 7: e29051. PMID 22253702 DOI: 10.1371/Journal.Pone.0029051 |
0.615 |
|
| 2012 |
RodrÃguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Cheung L, Wacholder S, Burk RD. Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3. International Journal of Cancer. Journal International Du Cancer. 131: 1874-81. PMID 22213126 DOI: 10.1002/Ijc.27418 |
0.756 |
|
| 2012 |
Marks MA, Castle PE, Schiffman M, Gravitt PE. Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer. Journal of Clinical Microbiology. 50: 300-6. PMID 22162556 DOI: 10.1128/Jcm.05979-11 |
0.816 |
|
| 2012 |
Markt SC, Rodriguez AC, Burk RD, Hildesheim A, Herrero R, Wacholder S, Hutchinson M, Schiffman M. Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting. The Journal of Infectious Diseases. 205: 498-505. PMID 22147792 DOI: 10.1093/Infdis/Jir746 |
0.731 |
|
| 2012 |
Gage JC, Sadorra M, LaMere BJ, Kail R, Aldrich C, Kinney W, Fetterman B, Lorey T, Schiffman M, Castle PE. Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests Journal of Clinical Microbiology. 50: 61-65. PMID 22075592 DOI: 10.1128/Jcm.05989-11 |
0.753 |
|
| 2012 |
Schiffman M, Wacholder S. Success of HPV vaccination is now a matter of coverage Lancet Oncology. 13: 10-12. PMID 22075169 DOI: 10.1016/S1470-2045(11)70324-2 |
0.623 |
|
| 2012 |
Kreimer AR, Schiffman M, Herrero R, Hildesheim A, González P, Burk RD, Porras C, Sherman ME, Demuth F, Cheung L, Bratti C, Cecilia Rodríguez A. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. International Journal of Cancer. Journal International Du Cancer. 131: 211-8. PMID 21823117 DOI: 10.1002/Ijc.26349 |
0.74 |
|
| 2012 |
Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. International Journal of Cancer. Journal International Du Cancer. 130: 2111-7. PMID 21630264 DOI: 10.1002/Ijc.26211 |
0.722 |
|
| 2012 |
Porras C, Wentzensen N, RodrÃguez AC, Morales J, Burk RD, Alfaro M, Hutchinson M, Herrero R, Hildesheim A, Sherman ME, Wacholder S, Solomon D, Schiffman M. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy. International Journal of Cancer. Journal International Du Cancer. 130: 1879-87. PMID 21607948 DOI: 10.1002/Ijc.26194 |
0.744 |
|
| 2012 |
Alter BP, Giri N, Pan Y, Quint W, Koning Md, Schiffman M, Pinto L. The HPV Status of Patients with Fanconi Anemia. Blood. 120: 2362-2362. DOI: 10.1182/Blood.V120.21.2362.2362 |
0.725 |
|
| 2012 |
Schiffman M. Abstract IA16: Susceptibility to neoplasia following HPV infection. Cancer Epidemiology Biomarkers & Prevention. 21: IA16-IA16. DOI: 10.1158/1055-9965.Gwas-Ia16 |
0.687 |
|
| 2012 |
Zhao L, Wentzensen N, Zhang R, Dunn S, Gold M, Wang S, Schiffman M, Walker J, Zuna R. Accuracy-Reducing Factors in Pap Tests for Women with Invasive Cervical Cancer Journal of the American Society of Cytopathology. 1. DOI: 10.1016/J.Jasc.2012.08.004 |
0.532 |
|
| 2011 |
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE. Cervical cancer risk for 330,000 women undergoing concurrent HPV testing and cervical cytology in routine clinical practice. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1508. PMID 28023624 DOI: 10.1200/Jco.2011.29.15_Suppl.1508 |
0.733 |
|
| 2011 |
Herrero R, Wacholder S, RodrÃguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A, et al. Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discovery. 1: 408-19. PMID 22586631 DOI: 10.1158/2159-8290.Cd-11-0131 |
0.706 |
|
| 2011 |
Castle PE, Gage JC, Wheeler CM, Schiffman M. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstetrics and Gynecology. 118: 1222-9. PMID 22105250 DOI: 10.1097/Aog.0B013E318237Caf4 |
0.726 |
|
| 2011 |
Zuna RE, Tuller E, Wentzensen N, Mathews C, Allen RA, Shanesmith R, Dunn ST, Gold MA, Wang SS, Walker J, Schiffman M. HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infectious Agents and Cancer. 6: 19. PMID 22035468 DOI: 10.1186/1750-9378-6-19 |
0.714 |
|
| 2011 |
Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, Scarinci I, Castle PE. Comparative performance of human papillomavirus DNA testing using novel sample collection methods. Journal of Clinical Microbiology. 49: 4185-9. PMID 21998422 DOI: 10.1128/Jcm.01254-11 |
0.737 |
|
| 2011 |
Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, et al. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sexually Transmitted Diseases. 38: 976-82. PMID 21934576 DOI: 10.1097/Olq.0B013E31822545C0 |
0.832 |
|
| 2011 |
Schiffman M, Gage JC, Clarke MA. Accepting the universal truths of cervical human papillomavirus epidemiology in pursuit of the remaining mysteries. Sexually Transmitted Diseases. 38: 907-8. PMID 21934561 DOI: 10.1097/Olq.0B013E318224A63F |
0.631 |
|
| 2011 |
Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S, et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. Journal of the National Cancer Institute. 103: 1444-51. PMID 21908768 DOI: 10.1093/Jnci/Djr319 |
0.646 |
|
| 2011 |
Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, Hsieh CY, Liaw KL, Hsing AW, Chen CJ. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. Journal of the National Cancer Institute. 103: 1387-96. PMID 21900119 DOI: 10.1093/Jnci/Djr283 |
0.77 |
|
| 2011 |
Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, et al. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. The Lancet. Oncology. 12: 862-70. PMID 21865087 DOI: 10.1016/S1470-2045(11)70213-3 |
0.712 |
|
| 2011 |
Bottalico D, Chen Z, Dunne A, Ostoloza J, McKinney S, Sun C, Schlecht NF, Fatahzadeh M, Herrero R, Schiffman M, Burk RD. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. The Journal of Infectious Diseases. 204: 787-92. PMID 21844305 DOI: 10.1093/Infdis/Jir383 |
0.71 |
|
| 2011 |
Clarke MA, Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Wacholder S, Burk RD, Schiffman M. A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infectious Agents and Cancer. 6: 12. PMID 21801395 DOI: 10.1186/1750-9378-6-12 |
0.676 |
|
| 2011 |
Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez AC, Hildesheim A, Burk RD, Plummer M. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. The Journal of Infectious Diseases. 204: 385-90. PMID 21742837 DOI: 10.1093/Infdis/Jir286 |
0.658 |
|
| 2011 |
Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, Desalle R, Herrero R, Yu K, Wacholder S, Wang T, Burk RD. Sequence imputation of HPV16 genomes for genetic association studies. Plos One. 6: e21375. PMID 21731721 DOI: 10.1371/Journal.Pone.0021375 |
0.693 |
|
| 2011 |
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice The Lancet Oncology. 12: 663-672. PMID 21684207 DOI: 10.1016/S1470-2045(11)70145-0 |
0.717 |
|
| 2011 |
Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. Plos One. 6: e20183. PMID 21673791 DOI: 10.1371/Journal.Pone.0020183 |
0.815 |
|
| 2011 |
Castle PE, Gutierrez EC, Leitch SV, Maus CE, McMillian RA, Nussbaumer WA, Vaughan LM, Wheeler CM, Gravitt PE, Schiffman M. Evaluation of a new DNA test for detection of carcinogenic human papillomavirus. Journal of Clinical Microbiology. 49: 3029-32. PMID 21632892 DOI: 10.1128/Jcm.00422-11 |
0.812 |
|
| 2011 |
Wentzensen N, Rodriguez AC, Viscidi R, Herrero R, Hildesheim A, Ghosh A, Morales J, Wacholder S, Guillen D, Alfaro M, Safaeian M, Burk RD, Schiffman M. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study. The Journal of Infectious Diseases. 204: 94-102. PMID 21628663 DOI: 10.1093/Infdis/Jir209 |
0.79 |
|
| 2011 |
Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, Buckland J, Sherman ME, Rydzak G, Kirk P, Lorincz AT, Wacholder S, Burk RD. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1398-409. PMID 21602310 DOI: 10.1158/1055-9965.Epi-11-0206 |
0.744 |
|
| 2011 |
Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 946-53. PMID 21415357 DOI: 10.1158/1055-9965.Epi-10-1267 |
0.766 |
|
| 2011 |
Xi LF, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M. Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study. The Journal of Infectious Diseases. 203: 1425-33. PMID 21415020 DOI: 10.1093/Infdis/Jir049 |
0.661 |
|
| 2011 |
Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. The Journal of Infectious Diseases. 203: 910-20. PMID 21402543 DOI: 10.1093/Infdis/Jiq139 |
0.703 |
|
| 2011 |
Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Schiffman M, Demuth F, Kinney W. Variable risk of cervical precancer and cancer after a human papillomavirus-positive test Obstetrics and Gynecology. 117: 650-656. PMID 21343769 DOI: 10.1097/Aog.0B013E318209Da59 |
0.72 |
|
| 2011 |
Castle PE, Rodríguez AC, Burk RD, Herrero R, Wacholder S, Hildesheim A, Morales J, Rydzak G, Schiffman M. Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer. The Journal of Infectious Diseases. 203: 814-22. PMID 21343148 DOI: 10.1093/Infdis/Jiq116 |
0.656 |
|
| 2011 |
Schiffman M. The Need for Forward-Looking Decision Analyses to Guide Cervical Cancer Prevention Cancer Epidemiology, Biomarkers & Prevention. 20: 219-220. PMID 21300615 DOI: 10.1158/1055-9965.Epi-10-1130 |
0.7 |
|
| 2011 |
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. Journal of the National Cancer Institute. 103: 368-83. PMID 21282563 DOI: 10.1093/Jnci/Djq562 |
0.761 |
|
| 2011 |
Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M. Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. The Journal of Infectious Diseases. 203: 823-7. PMID 21257737 DOI: 10.1093/Infdis/Jiq131 |
0.667 |
|
| 2011 |
Chen HC, You SL, Hsieh CY, Schiffman M, Lin CY, Pan MH, Chou YC, Liaw KL, Hsing AW, Chen CJ. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women. International Journal of Cancer. Journal International Du Cancer. 128: 1192-203. PMID 20853317 DOI: 10.1002/Ijc.25685 |
0.754 |
|
| 2011 |
Rodríguez AC, García-Piñeres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmella I, Ramírez M, Villegas M, Schiffman M, Burk R, Freer E, Bonilla J, Bratti C, Pinto LA. Alterations of T-cell surface markers in older women with persistent human papillomavirus infection. International Journal of Cancer. 128: 597-607. PMID 20473864 DOI: 10.1002/Ijc.25371 |
0.682 |
|
| 2011 |
Wentzensen NA, Walker J, Zuna R, Smith K, Mathews C, Moxley K, Tenney M, Zhang R, Gold M, Schiffman M. Abstract 3189: Misclassification of cervical precancer: Impact of a new colposcopy protocol on disease ascertainment and biomarker performance Cancer Research. 71: 3189-3189. DOI: 10.1158/1538-7445.Am2011-3189 |
0.639 |
|
| 2011 |
Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Wacholder S, Lorincz A, Burk RD. Abstract 1991: Methylation of the HPV16 L1 gene is associated with disease progression in a prospective population-based cohort Cancer Research. 71: 1991-1991. DOI: 10.1158/1538-7445.Am2011-1991 |
0.557 |
|
| 2011 |
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE. Premature conclusions on HPV-only testing - Authors' reply The Lancet Oncology. 12: 993. DOI: 10.1016/S1470-2045(11)70240-6 |
0.705 |
|
| 2010 |
Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. Journal of the National Cancer Institute. 102: 1794-804. PMID 21098758 DOI: 10.1093/Jnci/Djq436 |
0.839 |
|
| 2010 |
Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Hulbert A, Schiffman M, Kiviat NB. Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections. The Journal of Infectious Diseases. 202: 1667-70. PMID 20977339 DOI: 10.1086/657083 |
0.736 |
|
| 2010 |
Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research. 70: 8578-86. PMID 20959485 DOI: 10.1158/0008-5472.Can-10-1188 |
0.827 |
|
| 2010 |
González P, Hildesheim A, Rodríguez AC, Schiffman M, Porras C, Wacholder S, Piñeres AG, Pinto LA, Burk RD, Herrero R. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 3044-54. PMID 20952561 DOI: 10.1158/1055-9965.Epi-10-0645 |
0.725 |
|
| 2010 |
Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Gonzalez P, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. Journal of the National Cancer Institute. 102: 1653-62. PMID 20944077 DOI: 10.1093/jnci/djq384 |
0.841 |
|
| 2010 |
Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffman M, et al. Determinants of seropositivity among HPV-16/18 DNA positive young women. Bmc Infectious Diseases. 10: 238. PMID 20698998 DOI: 10.1186/1471-2334-10-238 |
0.848 |
|
| 2010 |
Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, et al. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Sexually Transmitted Diseases. 37: 706-14. PMID 20661178 DOI: 10.1097/Olq.0B013E3181E1A2C5 |
0.84 |
|
| 2010 |
Kemp TJ, Hildesheim A, GarcÃa-Piñeres A, Williams MC, Shearer GM, Rodriguez AC, Schiffman M, Burk R, Freer E, Bonilla J, Herrero R, Pinto LA. Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1954-9. PMID 20647411 DOI: 10.1158/1055-9965.Epi-10-0184 |
0.49 |
|
| 2010 |
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1675-81. PMID 20615885 DOI: 10.1158/1055-9965.Epi-10-0251 |
0.814 |
|
| 2010 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Castle PE. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1668-74. PMID 20615884 DOI: 10.1158/1055-9965.Epi-09-1286 |
0.737 |
|
| 2010 |
Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer Obstetrics and Gynecology. 116: 177-185. PMID 20567185 DOI: 10.1097/Aog.0B013E3181E4629F |
0.581 |
|
| 2010 |
Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Research. 70: 3159-69. PMID 20354192 DOI: 10.1158/0008-5472.Can-09-4179 |
0.857 |
|
| 2010 |
Cortés B, Schiffman M, Herrero R, Hildesheim A, Jiménez S, Shea K, González P, Porras C, Fallas G, Rodríguez AC. Establishment and Operation of a Biorepository for Molecular Epidemiologic Studies in Costa Rica Cancer Epidemiology, Biomarkers & Prevention. 19: 916-922. PMID 20332271 DOI: 10.1158/1055-9965.Epi-10-0066 |
0.533 |
|
| 2010 |
Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, RodrÃguez AC, Solomon D, Herrero R, Schiffman M. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. Bmj (Clinical Research Ed.). 340: c712. PMID 20197322 DOI: 10.1136/Bmj.C712 |
0.653 |
|
| 2010 |
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. Journal of the National Cancer Institute. 102: 315-24. PMID 20157096 DOI: 10.1093/Jnci/Djq001 |
0.711 |
|
| 2010 |
Wang SS, Gonzalez P, Yu K, Porras C, Li Q, Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, Wacholder S, Burk RD, Herrero R, Chanock SJ, Hildesheim A. Common genetic variants and risk for HPV persistence and progression to cervical cancer. Plos One. 5: e8667. PMID 20084279 DOI: 10.1371/Journal.Pone.0008667 |
0.788 |
|
| 2010 |
Safaeian M, van Doorslaer K, Schiffman M, Chen Z, Rodriguez AC, Herrero R, Hildesheim A, Burk RD. Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Archives of Virology. 155: 367-70. PMID 20049619 DOI: 10.1007/S00705-009-0579-2 |
0.849 |
|
| 2010 |
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Impact of improved classification on the association of human papillomavirus with cervical precancer. American Journal of Epidemiology. 171: 155-63. PMID 20007673 DOI: 10.1093/Aje/Kwp390 |
0.823 |
|
| 2010 |
Maucort-Boulch D, Plummer M, Castle PE, Demuth F, Safaeian M, Wheeler CM, Schiffman M. Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. International Journal of Cancer. Journal International Du Cancer. 126: 684-91. PMID 19609952 DOI: 10.1002/Ijc.24752 |
0.824 |
|
| 2010 |
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: Critical role of duration of infection Obstetrical & Gynecological Survey. 65: 374-376. DOI: 10.1097/Ogx.0B013E3181E5A0Ed |
0.662 |
|
| 2009 |
Castle PE, Wentzensen N, Wheeler CM, Rydzak G, Schiffman M. Effect of the number of biopsies on the subsequent acquisition of new human papillomavirus infections. Obstetrics and Gynecology. 114: 1057-62. PMID 20168107 DOI: 10.1097/Aog.0B013E3181Bb5632 |
0.738 |
|
| 2009 |
Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, Ho J, Schiffman M. Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3490-6. PMID 19959700 DOI: 10.1158/1055-9965.Epi-09-0763 |
0.653 |
|
| 2009 |
Schiffman M, Solomon D. Screening and Prevention Methods for Cervical Cancer Jama. 302: 1809-1810. PMID 19861676 DOI: 10.1001/Jama.2009.1573 |
0.468 |
|
| 2009 |
Xi LF, Hughes JP, Edelstein ZR, Kiviat NB, Koutsky LA, Mao C, Ho J, Schiffman M. Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up. The Journal of Infectious Diseases. 200: 1789-97. PMID 19848609 DOI: 10.1086/647993 |
0.751 |
|
| 2009 |
Solomon D, Castle PE, Hildesheim A, Katki HA, Schiffman M, Wacholder S. HPV vaccination in women aged 24-45 years. The Lancet. 374: 1239. PMID 19819386 DOI: 10.1016/S0140-6736(09)61782-7 |
0.648 |
|
| 2009 |
Schiffman M, Safaeian M, Wentzensen N. The use of human papillomavirus seroepidemiology to inform vaccine policy. Sexually Transmitted Diseases. 36: 675-9. PMID 19773679 DOI: 10.1097/Olq.0B013E3181Bce102 |
0.825 |
|
| 2009 |
Wentzensen N, Zuna RE, Sherman ME, Gold MA, Schiffman M, Dunn ST, Jeronimo J, Zhang R, Walker J, Wang SS. Accuracy of cervical specimens obtained for biomarker studies in women with CIN3 Gynecologic Oncology. 115: 493-496. PMID 19773045 DOI: 10.1016/J.Ygyno.2009.09.001 |
0.6 |
|
| 2009 |
Katki HA, Wacholder S, Solomon D, Castle PE, Schiffman M. Risk estimation for the next generation of prevention programmes for cervical cancer Lancet Oncology. 10: 1022-1023. PMID 19767237 DOI: 10.1016/S1470-2045(09)70253-0 |
0.57 |
|
| 2009 |
Xi LF, Edelstein ZR, Meyers C, Ho J, Cherne SL, Schiffman M. Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2507-12. PMID 19690188 DOI: 10.1158/1055-9965.Epi-09-0482 |
0.729 |
|
| 2009 |
Castle PE, Rodríguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D, Schiffman M. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. Bmj (Clinical Research Ed.). 339: b2569. PMID 19638649 DOI: 10.1136/Bmj.B2569 |
0.714 |
|
| 2009 |
Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. International Journal of Cancer. Journal International Du Cancer. 125: 2151-8. PMID 19585494 DOI: 10.1002/Ijc.24528 |
0.745 |
|
| 2009 |
Castle PE, Rodríguez AC, Burk RD, Herrero R, Hildesheim A, Solomon D, Sherman ME, Jeronimo J, Alfaro M, Morales J, Guillén D, Hutchinson ML, Wacholder S, Schiffman M. Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer. International Journal of Cancer. Journal International Du Cancer. 125: 1649-56. PMID 19569231 DOI: 10.1002/Ijc.24525 |
0.666 |
|
| 2009 |
Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. International Journal of Cancer. 125: 2609-13. PMID 19569178 DOI: 10.1002/Ijc.24706 |
0.699 |
|
| 2009 |
Gage JC, Rodriguez AC, Schiffman M, Garcia FM, Long RL, Budihas SR, Herrero R, Burk RD, Jeronimo J. Treatability by cryotherapy in a screen-and-treat strategy. Journal of Lower Genital Tract Disease. 13: 174-81. PMID 19550216 DOI: 10.1097/Lgt.0B013E3181909F30 |
0.676 |
|
| 2009 |
Massad LS, Jeronimo J, Katki HA, Schiffman M, Antani S, Boardman L, Cartwright P, Castle P, Dunton C, Gage J, Guido R, Guijon F, Herzog T, Huh W, Korn A, et al. The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia Journal of Lower Genital Tract Disease. 13: 137-144. PMID 19550210 DOI: 10.1097/Lgt.0B013E31819308D4 |
0.569 |
|
| 2009 |
Gage JC, Rodriguez AC, Schiffman M, Adadevoh S, Larraondo MJ, Chumworathayi B, Lejarza SV, Araya LV, Garcia F, Budihas SR, Long R, Katki HA, Herrero R, Burk RD, Jeronimo J. An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 728-33. PMID 19509579 DOI: 10.1111/Igc.0B013E3181A48B99 |
0.663 |
|
| 2009 |
Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Infectious Agents and Cancer. 4: 8-8. PMID 19486508 DOI: 10.1186/1750-9378-4-8 |
0.743 |
|
| 2009 |
Koshiol J, Hildesheim A, Gonzalez P, Bratti MC, Porras C, Schiffman M, Herrero R, Rodriguez AC, Wacholder S, Yeager M, Chanock SJ, Burk RD, Wang SS. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1631-7. PMID 19423538 DOI: 10.1158/1055-9965.Epi-08-0830 |
0.535 |
|
| 2009 |
Castle PE, Kreimer AR, Wacholder S, Wheeler CM, Koutsky LA, Rydzak G, Buckman DW, Graubard B, Schiffman M. Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections. The Journal of Infectious Diseases. 199: 1612-20. PMID 19405865 DOI: 10.1086/598981 |
0.618 |
|
| 2009 |
Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Research. 69: 3262-6. PMID 19351830 DOI: 10.1158/0008-5472.Can-08-4192 |
0.859 |
|
| 2009 |
Schiffman M, Wacholder S. From India to the world--a better way to prevent cervical cancer. The New England Journal of Medicine. 360: 1453-1455. PMID 19339726 DOI: 10.1056/Nejme0901167 |
0.66 |
|
| 2009 |
Porras C, Rodríguez AC, Hildesheim A, Herrero R, González P, Wacholder S, Burk RD, Schiffman M. Human papillomavirus types by age in cervical cancer precursors: Predominance of human papillomavirus 16 in young women Cancer Epidemiology Biomarkers and Prevention. 18: 863-865. PMID 19273486 DOI: 10.1158/1055-9965.Epi-08-0951 |
0.746 |
|
| 2009 |
Hildesheim A, Schiffman M, Solomon D, Wacholder S, Rodriguez AC, Herrero R. Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al. Vaccine. 27: 2529-2529. PMID 19186195 DOI: 10.1016/J.Vaccine.2009.01.028 |
0.481 |
|
| 2009 |
Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, et al. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 113-20. PMID 19124488 DOI: 10.1158/1055-9965.Epi-08-0591 |
0.868 |
|
| 2009 |
Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstetrics and Gynecology. 113: 18-25. PMID 19104355 DOI: 10.1097/01.Ogx.0000347334.07172.51 |
0.731 |
|
| 2009 |
Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science Gynecologic Oncology. 112: 293-299. PMID 19054549 DOI: 10.1016/J.Ygyno.2008.10.012 |
0.497 |
|
| 2009 |
Chen Z, DeSalle R, Schiffman M, Herrero R, Burk RD. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. Journal of Virology. 83: 1443-55. PMID 19036820 DOI: 10.1128/Jvi.02068-08 |
0.729 |
|
| 2009 |
Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, Zhang R, Sherman ME, Wacholder S, Jeronimo J, Gold MA, Wang SS. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. International Journal of Cancer. Journal International Du Cancer. 124: 964-9. PMID 19030188 DOI: 10.1002/Ijc.23969 |
0.735 |
|
| 2009 |
Wang SS, Bratti MC, Rodríguez AC, Herrero R, Burk RD, Porras C, González P, Sherman ME, Wacholder S, Lan ZE, Schiffman M, Chanock SJ, Hildesheim A. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. The Journal of Infectious Diseases. 199: 20-30. PMID 19012493 DOI: 10.1086/595563 |
0.671 |
|
| 2009 |
Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Evaluación del riesgo como guía en la prevención de cáncer cervical Journal of Lower Genital Tract Disease. 2: 5-12. DOI: 10.1097/00128360-200904001-00002 |
0.53 |
|
| 2008 |
Castle PE, Solomon D, Saslow D, Schiffman M. Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States. Cancer. 113: 3031-3035. PMID 18980285 DOI: 10.1002/Cncr.23762 |
0.547 |
|
| 2008 |
Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Muñoz N, Schiffman M, Bosch FX. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 26: K17-28. PMID 18847554 DOI: 10.1016/J.Vaccine.2008.06.021 |
0.76 |
|
| 2008 |
Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia Vaccine. 26. PMID 18847553 DOI: 10.1016/J.Vaccine.2008.05.064 |
0.75 |
|
| 2008 |
Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer. 113: 1980-93. PMID 18798536 DOI: 10.1002/cncr.23704 |
0.462 |
|
| 2008 |
Castle PE, Cox JT, Schiffman M, Wheeler CM, Solomon D. Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstetrics and Gynecology. 112: 637-45. PMID 18757663 DOI: 10.1097/Aog.0B013E3181834637 |
0.677 |
|
| 2008 |
Castle PE, Porras C, Quint WG, Rodriguez AC, Schiffman M, Gravitt PE, González P, Katki HA, Silva S, Freer E, Van Doorn LJ, Jiménez S, Herrero R, Hildesheim A. Comparison of two PCR-based human papillomavirus genotyping methods. Journal of Clinical Microbiology. 46: 3437-45. PMID 18716224 DOI: 10.1128/Jcm.00620-08 |
0.821 |
|
| 2008 |
Herrero R, Hildesheim A, RodrÃguez AC, Wacholder S, Bratti C, Solomon D, González P, Porras C, Jiménez S, Guillen D, Morales J, Alfaro M, Cyr J, Morrisey K, Estrada Y, ... ... Schiffman M, et al. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine. 26: 4795-808. PMID 18640170 DOI: 10.1016/J.Vaccine.2008.07.002 |
0.714 |
|
| 2008 |
Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. Journal of Clinical Microbiology. 46: 2595-604. PMID 18579716 DOI: 10.1128/Jcm.00824-08 |
0.83 |
|
| 2008 |
Galgano MT, Castle PE, Stoler MH, Solomon D, Schiffman M. Can HPV-16 genotyping provide a benchmark for cervical biopsy specimen interpretation? American Journal of Clinical Pathology. 130: 65-70. PMID 18550472 DOI: 10.1309/A8Mfc18Twanc8Qfh |
0.731 |
|
| 2008 |
Massad LS, Jeronimo J, Schiffman M. Interobserver agreement in the assessment of components of colposcopic grading. Obstetrics & Gynecology. 111: 1279-1284. PMID 18515509 DOI: 10.1097/Aog.0B013E31816Baed1 |
0.432 |
|
| 2008 |
Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1248-54. PMID 18483347 DOI: 10.1158/1055-9965.Epi-07-2904 |
0.759 |
|
| 2008 |
Schiffman M, Rodríguez AC. Heterogeneity in CIN3 diagnosis. Lancet Oncology. 9: 404-406. PMID 18452848 DOI: 10.1016/S1470-2045(08)70110-4 |
0.317 |
|
| 2008 |
Porras C, Safaeian M, González P, Hildesheim A, Silva S, Schiffman M, Rodríguez AC, Wacholder S, Freer E, Quint K, Bratti C, Espinoza A, Cortes B, Herrero R. Epidemiology of genital chlamydia trachomatis infection among young women in Costa Rica Sexually Transmitted Diseases. 35: 461-468. PMID 18446086 DOI: 10.1097/Olq.0B013E3181644B4C |
0.636 |
|
| 2008 |
Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, Gravitt PE, Schiffman M. An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS). Obstetrics and Gynecology. 111: 847-56. PMID 18378743 DOI: 10.1097/Aog.0B013E318168460B |
0.8 |
|
| 2008 |
Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R. Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections Journal of the National Cancer Institute. 100: 513-517. PMID 18364507 DOI: 10.1093/Jnci/Djn044 |
0.707 |
|
| 2008 |
Gage JC, Safaeian M, Jeronimo J, Schiffman M. Spectroscopic imaging as triage test for cervical disease. Journal of Lower Genital Tract Disease. 12: 52-3. PMID 18162814 DOI: 10.1097/Lgt.0B013E318149E232 |
0.686 |
|
| 2008 |
Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk Assessment to Guide the Prevention of Cervical Cancer Journal of Lower Genital Tract Disease. 12: 1-7. PMID 18162804 DOI: 10.1097/Lgt.0B013E31815Ea58B |
0.436 |
|
| 2008 |
Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. Journal of Clinical Microbiology. 46: 109-17. PMID 17989194 DOI: 10.1128/Jcm.01667-07 |
0.828 |
|
| 2007 |
Quint K, Porras C, Safaeian M, González P, Hildesheim A, Quint W, van Doorn LJ, Silva S, Melchers W, Schiffman M, Rodríguez AC, Wacholder S, Freer E, Cortes B, Herrero R, et al. Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens. Journal of Clinical Microbiology. 45: 3986-91. PMID 17959760 DOI: 10.1128/JCM.01155-07 |
0.59 |
|
| 2007 |
Chen Z, Schiffman M, Herrero R, Burk RD. Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106 Journal of General Virology. 88: 2952-2955. PMID 17947516 DOI: 10.1099/Vir.0.83178-0 |
0.725 |
|
| 2007 |
Jeronimo J, Massad LS, Castle PE, Wacholder S, Schiffman M. Interobserver agreement in the evaluation of digitized cervical images. Obstetrics & Gynecology. 110: 833-840. PMID 17906017 DOI: 10.1097/01.Aog.0000281665.63550.8F |
0.476 |
|
| 2007 |
Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer American Journal of Obstetrics and Gynecology. 197: 356-358. PMID 17904958 DOI: 10.1016/J.Ajog.2007.07.049 |
0.488 |
|
| 2007 |
Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 26: 441-6. PMID 17885496 DOI: 10.1097/Pgp.0B013E31805152Ab |
0.715 |
|
| 2007 |
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer The Lancet. 370: 890-907. PMID 17826171 DOI: 10.1016/S0140-6736(07)61416-0 |
0.711 |
|
| 2007 |
Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease International Journal of Cancer. 121: 2787-2793. PMID 17722112 DOI: 10.1002/Ijc.23012 |
0.787 |
|
| 2007 |
Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. Journal of Clinical Microbiology. 45: 3245-50. PMID 17699644 DOI: 10.1128/Jcm.00216-07 |
0.818 |
|
| 2007 |
Solomon D, Stoler M, Jeronimo J, Khan M, Castle PE, Schiffman M. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstetrics & Gynecology. 110: 288-295. PMID 17666602 DOI: 10.1097/01.Aog.0000270154.69879.09 |
0.422 |
|
| 2007 |
Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD. A comparison of cervical and vaginal human papillomavirus Sexually Transmitted Diseases. 34: 849-855. PMID 17621246 DOI: 10.1097/Olq.0B013E318064C8C5 |
0.74 |
|
| 2007 |
Jeronimo J, Massad LS, Schiffman M. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. American Journal of Obstetrics and Gynecology. 197: 47. PMID 17618753 DOI: 10.1016/J.Ajog.2007.02.047 |
0.723 |
|
| 2007 |
Pratt MM, Sirajuddin P, Poirier MC, Schiffman M, Glass AG, Scott DR, Rush BB, Olivero OA, Castle PE. Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study. Mutation Research. 624: 114-23. PMID 17583755 DOI: 10.1016/J.Mrfmmm.2007.04.008 |
0.601 |
|
| 2007 |
Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance. Obstetrics and Gynecology. 109: 1325-31. PMID 17540804 DOI: 10.1097/01.Aog.0000263461.71732.40 |
0.845 |
|
| 2007 |
Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer. 111: 145-53. PMID 17487850 DOI: 10.1002/cncr.22751 |
0.551 |
|
| 2007 |
Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer. 111: 145-53. PMID 17487850 DOI: 10.1002/cncr.22751 |
0.551 |
|
| 2007 |
Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. The Journal of Infectious Diseases. 195: 1582-9. PMID 17471427 DOI: 10.1086/516784 |
0.68 |
|
| 2007 |
Castle PE, Stoler MH, Solomon D, Schiffman M. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. American Journal of Clinical Pathology. 127: 805-815. PMID 17439841 DOI: 10.1309/Pt3Pnc1Ql2F4D2Vl |
0.678 |
|
| 2007 |
Dunn ST, Allen RA, Wang S, Walker J, Schiffman M. DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. Journal of Virological Methods. 143: 45-54. PMID 17399803 DOI: 10.1016/J.Jviromet.2007.02.006 |
0.613 |
|
| 2007 |
Chen Z, Fu L, Herrero R, Schiffman M, Burk RD. Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45 International Journal of Cancer. 121: 193-198. PMID 17351898 DOI: 10.1002/Ijc.22632 |
0.744 |
|
| 2007 |
Stoler MH, Castle PE, Solomon D, Schiffman M. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. American Journal of Clinical Pathology. 127: 335-7. PMID 17276947 DOI: 10.1309/RNF3C01JKADQCLKP |
0.516 |
|
| 2007 |
Rodriguez AC, Burk R, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Viscidi R, Morales J, Hutchinson M, Wacholder S, Schiffman M. The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life. Sexually Transmitted Diseases. 34: 494-502. PMID 17237737 DOI: 10.1097/01.Olq.0000251241.03088.A0 |
0.72 |
|
| 2007 |
Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE. Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 11-6. PMID 17220326 DOI: 10.1158/1055-9965.Epi-06-0710 |
0.738 |
|
| 2007 |
Sherman ME, Dasgupta A, Schiffman M, Nayar R, Solomon D. The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology. Cancer. 111: 15-25. PMID 17186503 DOI: 10.1002/cncr.22423 |
0.458 |
|
| 2007 |
Chen Z, Schiffman M, Herrero R, Desalle R, Burk RD. Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology. 360: 447-53. PMID 17125811 DOI: 10.1016/J.Virol.2006.10.022 |
0.688 |
|
| 2007 |
Jeronimo J, Schiffman M. Colposcopy at a Crossroads Journal of Lower Genital Tract Disease. 11: 194. DOI: 10.1097/01.Lgt.0000265793.64612.51 |
0.607 |
|
| 2007 |
Walker JL, Wang SS, Schiffman M, Solomon D. Predicting Absolute Risk of Cervical Intraepithelial Neoplasia 3 during Postcolposcopic Follow-up: Results from the ASCUS-LSIL Triage Study Journal of Lower Genital Tract Disease. 11: 64. DOI: 10.1097/00128360-200701000-00024 |
0.538 |
|
| 2006 |
Castle PE, Schiffman M, Glass AG, Rush BB, Scott DR, Wacholder S, Dunn A, Burk RD. Human papillomavirus prevalence in women who have and have not undergone hysterectomies. The Journal of Infectious Diseases. 194: 1702-5. PMID 17109342 DOI: 10.1086/509511 |
0.751 |
|
| 2006 |
García-Piñeres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmetlla I, Ramírez M, Villegas M, Schiffman M, Rodríguez AC, Burk RD, Hildesheim M, Freer E, Bonilla J, Bratti C, et al. Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women Cancer Research. 66: 11070-11076. PMID 17108147 DOI: 10.1158/0008-5472.Can-06-2034 |
0.723 |
|
| 2006 |
Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Concepción Bratti M, Hildesheim A, Morales J, Alfaro M, Burk RD. Relationships of Human Papillomavirus Type, Qualitative Viral Load, and Age with Cytologic Abnormality Cancer Research. 66: 10112-10119. PMID 17047075 DOI: 10.1158/0008-5472.Can-06-1812 |
0.723 |
|
| 2006 |
Wheeler CM, Hunt WC, Schiffman M, Castle PE. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. The Journal of Infectious Diseases. 194: 1291-9. PMID 17041856 DOI: 10.1086/507909 |
0.747 |
|
| 2006 |
Zuna RE, Wang SS, Schiffman M, Solomon D. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 108: 288-97. PMID 16952155 DOI: 10.1002/Cncr.22168 |
0.692 |
|
| 2006 |
Moscicki A, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 24. PMID 16950017 DOI: 10.1016/J.Vaccine.2006.06.018 |
0.724 |
|
| 2006 |
Wang SS, Sherman ME, Rader JS, Carreon J, Schiffman M, Baker CC. Cervical tissue collection methods for RNA preservation: Comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation Diagnostic Molecular Pathology. 15: 144-148. PMID 16932069 DOI: 10.1097/01.Pdm.0000213460.53021.Cd |
0.317 |
|
| 2006 |
Walker JL, Wang SS, Schiffman M, Solomon D. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). American Journal of Obstetrics and Gynecology. 195: 341-8. PMID 16890545 DOI: 10.1016/J.Ajog.2006.02.047 |
0.387 |
|
| 2006 |
Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, Schiffman M, Solomon D, Jeronimo J. Number of cervical biopsies and sensitivity of colposcopy. Obstetrics and Gynecology. 108: 264-72. PMID 16880294 DOI: 10.1097/01.Aog.0000220505.18525.85 |
0.463 |
|
| 2006 |
Kreimer AR, Guido RS, Solomon D, Schiffman M, Wacholder S, Jeronimo J, Wheeler CM, Castle PE. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 908-14. PMID 16702369 DOI: 10.1158/1055-9965.Epi-05-0845 |
0.757 |
|
| 2006 |
Jeronimo J, Schiffman M. Colposcopy at a crossroads. American Journal of Obstetrics and Gynecology. 195: 349-353. PMID 16677597 DOI: 10.1016/J.Ajog.2006.01.091 |
0.684 |
|
| 2006 |
Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodríguez AC, Bratti MC, Hildesheim A, Wacholder S, Long LR, Neve L, Pfeiffer R, Burk RD. Age-related changes of the cervix influence human papillomavirus type distribution Cancer Research. 66: 1218-1224. PMID 16424061 DOI: 10.1158/0008-5472.Can-05-3066 |
0.603 |
|
| 2006 |
Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute. 98: 92-100. PMID 16418511 DOI: 10.1093/Jnci/Djj009 |
0.682 |
|
| 2006 |
Schiffman M, Castle PE. When to test women for human papillomavirus. Bmj (Clinical Research Ed.). 332: 61-2. PMID 16410556 DOI: 10.1136/Bmj.332.7533.61 |
0.765 |
|
| 2006 |
Jeronimo J, Long LR, Neve L, Michael B, Antani S, Schiffman M. Digital tools for collecting data from cervigrams for research and training in colposcopy. Journal of Lower Genital Tract Disease. 10: 16-25. PMID 16378028 DOI: 10.1097/01.Lgt.0000194057.20485.5A |
0.339 |
|
| 2006 |
Wang SS, Walker JL, Schiffman M, Solomon D. Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2665-8. PMID 16284394 DOI: 10.1158/1055-9965.Epi-05-0151 |
0.727 |
|
| 2006 |
Zuna RE, Wang SS, Rosenthal DL, Jeronimo J, Schiffman M, Solomon D. Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer. 105: 253-62. PMID 15991244 DOI: 10.1002/Cncr.21232 |
0.695 |
|
| 2005 |
Schiffman M, Castle PE. The promise of global cervical-cancer prevention. The New England Journal of Medicine. 353: 2101-4. PMID 16291978 DOI: 10.1056/Nejmp058171 |
0.456 |
|
| 2005 |
Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. American Journal of Clinical Pathology. 124: 722-32. PMID 16203281 DOI: 10.1309/E067X0L1U3Cy37Nw |
0.474 |
|
| 2005 |
Guido RS, Jeronimo J, Schiffman M, Solomon D. The distribution of neoplasia arising on the cervix: results from the ALTS trial. American Journal of Obstetrics and Gynecology. 193: 1331-1337. PMID 16202722 DOI: 10.1016/J.Ajog.2005.05.008 |
0.449 |
|
| 2005 |
Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. Journal of the National Cancer Institute. 97: 1072-9. PMID 16030305 DOI: 10.1093/Jnci/Dji187 |
0.768 |
|
| 2005 |
Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. Journal of the National Cancer Institute. 97: 1066-71. PMID 16030304 DOI: 10.1093/Jnci/Dji186 |
0.73 |
|
| 2005 |
Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology International Journal of Cancer. 117: 1007-1012. PMID 15986443 DOI: 10.1002/Ijc.21279 |
0.698 |
|
| 2005 |
Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 337: 76-84. PMID 15914222 DOI: 10.1016/J.Virol.2005.04.002 |
0.757 |
|
| 2005 |
Wang SS, Dasgupta A, Sherman ME, Walker JL, Gold MA, Zuna R, Sakoda L, Wacholder S, Schiffman M, Baker CC. Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 14: 59-64. PMID 15905687 DOI: 10.1097/01.Pas.0000162754.45908.D4 |
0.351 |
|
| 2005 |
Castle PE, Schiffman M, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Wacholder S, Lorincz AT. Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1311-4. PMID 15894692 DOI: 10.1158/1055-9965.Epi-04-0799 |
0.689 |
|
| 2005 |
McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Wheeler CM. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology Cancer Epidemiology Biomarkers and Prevention. 14: 1165-1170. PMID 15894667 DOI: 10.1158/1055-9965.Epi-04-0918 |
0.608 |
|
| 2005 |
Khan MJ, Partridge EE, Wang SS, Schiffman M. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer. 104: 61-70. PMID 15889450 DOI: 10.1002/Cncr.21129 |
0.702 |
|
| 2005 |
Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica Journal of Infectious Diseases. 191: 1808-1816. PMID 15871112 DOI: 10.1086/428779 |
0.675 |
|
| 2005 |
Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. The Journal of Infectious Diseases. 191: 1796-807. PMID 15871111 DOI: 10.1086/428850 |
0.684 |
|
| 2005 |
Khan MJ, Schiffman M, Jeronimo J. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in India International Journal of Cancer. 116: 830-831. PMID 15849748 DOI: 10.1002/Ijc.21084 |
0.561 |
|
| 2005 |
Jeronimo J, Khan MJ, Schiffman M, Solomon D. Does the interval between papanicolaou tests influence the quality of cytology Cancer. 105: 133-138. PMID 15822121 DOI: 10.1002/Cncr.21065 |
0.571 |
|
| 2005 |
Zelmanowicz Ade M, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscidi R, Schwartz P, Barnes W, Mortel R, Silverberg SG, Buckland J, Hildesheim A. Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States. International Journal of Cancer. Journal International Du Cancer. 116: 599-605. PMID 15818615 DOI: 10.1002/Ijc.21048 |
0.744 |
|
| 2005 |
Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. The Journal of Experimental Medicine. 201: 1069-75. PMID 15809352 DOI: 10.1084/Jem.20042158 |
0.326 |
|
| 2005 |
Wang SS, Schiffman M. Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 542-5. PMID 15734987 DOI: 10.1158/1055-9965.Epi-04-0642 |
0.552 |
|
| 2005 |
Khan MJ, Herrero R, Schiffman M. Re: Muñoz et al., "Against which human papillomavirus types shall we vaccinate and screen? The international perspective." Int J Cancer 2004;111:278-85 International Journal of Cancer. 115: 670. PMID 15704103 DOI: 10.1002/Ijc.20947 |
0.385 |
|
| 2005 |
Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Wacholder S, Kendal H, Breheny AM, Prior A, Pfeiffer R, Burk RD. PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 256-60. PMID 15668503 |
0.501 |
|
| 2005 |
Schiffman M, Khan MJ, Solomon D, Herrero R, Wacholder S, Hildesheim A, Rodriguez AC, Bratti MC, Wheeler CM, Burk RD. A study of the impact of adding HPV types to cervical cancer screening and triage test Journal of the National Cancer Institute. 97: 147-150. PMID 15657345 DOI: 10.1093/Jnci/Dji014 |
0.739 |
|
| 2005 |
Schiffman M, Castle PE, Solomon D, Stoler M, Wheeler C. RESPONSE: Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests Journal of the National Cancer Institute. 97: 939-941. DOI: 10.1093/Jnci/Dji160 |
0.664 |
|
| 2004 |
Rodríguez AC, Morera LA, Bratti C, Herrero R, Cox JT, Morales J, Alfaro M, Hutchinson M, Castle PE, Hildesheim A, Schiffman M. Performance of direct visual inspection of the cervix with acetic acid and magnification in a previously screened population. Journal of Lower Genital Tract Disease. 8: 132-8. PMID 15874851 DOI: 10.1097/00128360-200404000-00009 |
0.51 |
|
| 2004 |
Castle PE, Schiffman M, Wheeler CM. Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer American Journal of Obstetrics and Gynecology. 191: 1590-1597. PMID 15547529 DOI: 10.1016/J.Ajog.2004.05.018 |
0.605 |
|
| 2004 |
Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, Studentsov YY, McAdams M, Schiffman M. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1574-82. PMID 15466972 |
0.432 |
|
| 2004 |
Castle PE, Wheeler CM, Solomon D, Schiffman M, Peyton CL. Interlaboratory reliability of hybrid capture 2 American Journal of Clinical Pathology. 122: 238-245. PMID 15323141 DOI: 10.1309/ba43-hmca-j26v-wqh3 |
0.7 |
|
| 2004 |
Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, Burk RD, Hildesheim A, Bratti MC, Wright T, Rodriguez AC, Chen S, Reichert A, von Knebel Doeberitz C, Ridder R, von Knebel Doeberitz M. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1355-60. PMID 15298958 |
0.677 |
|
| 2004 |
Wang SS, Schiffman M, Herrero R, Carreon J, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Clayman B, Burk RD, Viscidi RP. Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. British Journal of Cancer. 91: 1269-74. PMID 15292929 DOI: 10.1038/sj.bjc.6602088 |
0.673 |
|
| 2004 |
Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, Hutchinson ML, Rodriguez AC, Wacholder S, Sherman ME, Kendall H, Viscidi RP, Jeronimo J, Schussler JE, Burk RD. A population-based study of vaginal human papillomavirus infection in hysterectomized women Journal of Infectious Diseases. 190: 458-467. PMID 15243917 DOI: 10.1086/421916 |
0.72 |
|
| 2004 |
Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 15: 75-89. PMID 15030652 DOI: 10.1590/S1020-49892004000200002 |
0.66 |
|
| 2004 |
Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, Sherman ME, Wang S, Clayman B, Burk RD. Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 324-7. PMID 14973086 DOI: 10.1158/1055-9965.Epi-03-0166 |
0.748 |
|
| 2004 |
Solomon D, Schiffman M. Have we resolved how to triage equivocal cervical cytology? Journal of the National Cancer Institute. 96: 250-1. PMID 14970266 DOI: 10.1093/jnci/djh063 |
0.605 |
|
| 2004 |
Wright TC, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C, Saslow D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstetrics and Gynecology. 103: 304-9. PMID 14754700 DOI: 10.1097/01.Aog.0000109426.82624.F8 |
0.715 |
|
| 2004 |
Shields TS, Falk RT, Herrero R, Schiffman M, Weiss NS, Bratti C, Rodriguez AC, Sherman ME, Burk RD, Hildesheim A. A case-control study of endogenous hormones and cervical cancer British Journal of Cancer. 90: 146-152. PMID 14710222 DOI: 10.1038/sj.bjc.6601514 |
0.586 |
|
| 2004 |
Solomon D, Schiffman M. RESPONSE: Re: Have We Resolved How To Triage Equivocal Cervical Cytology? Journal of the National Cancer Institute. 96: 1402-1402. DOI: 10.1093/Jnci/Djh278 |
0.576 |
|
| 2004 |
Cuzick J, Szarewski A, Cubie H, Castle PE, Schiffman M. Women with a positive HPV test can safely have yearly surveillance rather than immediate colposcopy Evidence-Based Obstetrics & Gynecology. 6: 150-151. DOI: 10.1016/J.Ebobgyn.2004.07.013 |
0.696 |
|
| 2003 |
Jeronimo J, Castle PE, Herrero R, Sherman ME, Bratti MC, Hildesheim A, Alfaro M, Morales J, Hutchinson ML, Burk RD, Lorincz A, Wacholder S, Rodríguez AC, Schiffman M. Right-sided ectocervical lesions may be associated with false-negative cytology among women with histologic cervical intraepithelial neoplasia 2 or 3. Journal of Lower Genital Tract Disease. 7: 175-83. PMID 17051065 DOI: 10.1097/00128360-200307000-00004 |
0.46 |
|
| 2003 |
Jeronimo J, Castle PE, Herrero R, Burk RD, Schiffman M. HPV testing and visual inspection for cervical cancer screening in resource-poor regions International Journal of Gynecology and Obstetrics. 83: 311-313. PMID 14643047 DOI: 10.1016/S0020-7292(03)00299-6 |
0.758 |
|
| 2003 |
Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M. Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions Cancer Epidemiology Biomarkers and Prevention. 12: 1038-1044. PMID 14578140 |
0.784 |
|
| 2003 |
Wang SS, Schiffman M, Shields TS, Herrero R, Hildesheim A, Bratti MC, Sherman ME, Rodriguez AC, Castle PE, Morales J, Alfaro M, Wright T, Chen S, Clayman B, Burk RD, et al. Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. British Journal of Cancer. 89: 1248-54. PMID 14520455 DOI: 10.1038/sj.bjc.6601272 |
0.663 |
|
| 2003 |
Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD, Morales J, Rodriguez AC, Schussler J, Eklund C, Marshall G, ... Schiffman M, et al. A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 815-23. PMID 14504189 |
0.613 |
|
| 2003 |
Castle PE, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Wacholder S, Burk RD, Manos MM, Schussler JE, Macomber P, Schiffman M. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. Journal of Clinical Microbiology. 41: 4022-30. PMID 12958220 DOI: 10.1128/Jcm.41.9.4022-4030.2003 |
0.681 |
|
| 2003 |
Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Archives of Pathology & Laboratory Medicine. 127: 946-949. PMID 12873166 DOI: 10.1043/1543-2165(2003)127<946:Ftdfta>2.0.Co;2 |
0.701 |
|
| 2003 |
Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Archives of Pathology & Laboratory Medicine. 127: 930-934. PMID 12873163 DOI: 10.1043/1543-2165(2003)127<930:Hpeaph>2.0.Co;2 |
0.726 |
|
| 2003 |
Castle PE, Escoffery C, Schachter J, Rattray C, Schiffman M, Moncada J, Sugai K, Brown C, Cranston B, Hanchard B, Palefsky JM, Burk RD, Hutchinson ML, Strickler HD. Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients Sexually Transmitted Diseases. 30: 575-580. PMID 12838087 DOI: 10.1097/00007435-200307000-00009 |
0.664 |
|
| 2003 |
Cox JT, Schiffman M, Solomon D. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. American Journal of Obstetrics and Gynecology. 188: 1406-12. PMID 12824970 DOI: 10.1067/Mob.2003.461 |
0.688 |
|
| 2003 |
Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. American Journal of Obstetrics and Gynecology. 188: 1401-5. PMID 12824969 DOI: 10.1067/mob.2003.456 |
0.556 |
|
| 2003 |
Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 477-84. PMID 12814990 |
0.717 |
|
| 2003 |
Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. Journal of the National Cancer Institute Monographs. 2003: 14-19. PMID 12807940 DOI: 10.1093/Oxfordjournals.Jncimonographs.A003476 |
0.749 |
|
| 2003 |
Gravitt PE, Hildesheim A, Herrero R, Schiffman M, Sherman ME, Bratti MC, Rodriguez AC, Morera LA, Cardenas F, Bowman FP, Shah KV, Crowley-Nowick PA. Correlates of IL-10 and IL-12 concentrations in cervical secretions. Journal of Clinical Immunology. 23: 175-83. PMID 12797539 DOI: 10.1023/A:1023305827971 |
0.63 |
|
| 2003 |
Castle PE, Solomon D, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Rodriguez AC, Alfaro M, Hutchinson ML, Dunn ST, Kuypers J, Schiffman M. Stability of archived liquid-based cervical cytologic specimens Cancer. 99: 89-96. PMID 12704688 DOI: 10.1002/cncr.11058 |
0.495 |
|
| 2003 |
Sherman ME, Wang SS, Tarone R, Rich L, Schiffman M. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: Implications for subject safety and lead-time bias Cancer Epidemiology Biomarkers and Prevention. 12: 372-379. PMID 12692113 |
0.46 |
|
| 2003 |
Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. Journal of the National Cancer Institute. 95: E2. PMID 12644550 DOI: 10.1093/jnci/95.6.e2 |
0.476 |
|
| 2003 |
Wright TC, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. The New England Journal of Medicine. 348: 489-90. PMID 12571255 DOI: 10.1056/Nejmp020178 |
0.708 |
|
| 2003 |
Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. Journal of the National Cancer Institute. 95: 46-52. PMID 12509400 DOI: 10.1093/Jnci/95.1.46 |
0.727 |
|
| 2003 |
Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis Obstetrical & Gynecological Survey. 58: 314-315. DOI: 10.1097/00006254-200305000-00014 |
0.703 |
|
| 2003 |
Bosch FX, Schiffman M, Solomon D. Introduction: Future Research Directions in the Epidemiology of Human Papillomavirus and Cancer Journal of the National Cancer Institute Monographs. 2003: 1-2. DOI: 10.1093/Oxfordjournals.Jncimonographs.A003470 |
0.735 |
|
| 2002 |
Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Concepcion Bratti M, Sherman ME, Lorincz A. Restricted cross-reactivity of Hybrid Capture 2 with nononcogenic human papillomavirus types Cancer Epidemiology Biomarkers and Prevention. 11: 1394-1399. PMID 12433717 |
0.606 |
|
| 2002 |
Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer. 95: 2145-51. PMID 12412168 DOI: 10.1002/cncr.10927 |
0.584 |
|
| 2002 |
Schiffman M, Wheeler CM, Castle PE. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities Journal of Infectious Diseases. 186: 1169-1172. PMID 12355370 DOI: 10.1086/343816 |
0.734 |
|
| 2002 |
Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. Journal of the National Cancer Institute. 94: 1406-14. PMID 12237286 DOI: 10.1093/Jnci/94.18.1406 |
0.598 |
|
| 2002 |
Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Concepcion Bratti M, Sherman ME, Lorincz A, Schussler JE, Burk RD. Comparisons of HPV DNA detection by MY09/11 PCR methods Journal of Medical Virology. 68: 417-423. PMID 12226831 DOI: 10.1002/Jmv.10220 |
0.801 |
|
| 2002 |
Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, et al. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. The Journal of Infectious Diseases. 186: 598-605. PMID 12195346 DOI: 10.1086/342295 |
0.482 |
|
| 2002 |
Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 360: 228-9. PMID 12133661 DOI: 10.1016/S0140-6736(02)09463-1 |
0.8 |
|
| 2002 |
Schneider DL, Burke L, Wright TC, Spitzer M, Chatterjee N, Wacholder S, Herrero R, Bratti MC, Greenberg MD, Hildesheim A, Sherman ME, Morales J, Hutchinson ML, Alfaro M, Lörincz A, ... Schiffman M, et al. Can cervicography be improved? An evaluation with arbitrated cervicography interpretations. American Journal of Obstetrics and Gynecology. 187: 15-23. PMID 12114883 DOI: 10.1067/Mob.2002.122848 |
0.388 |
|
| 2002 |
Studentsov YY, Schiffman M, Strickler HD, Ho GYF, Susana Pang YY, Schiller J, Herrero R, Burk RD. Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus Journal of Clinical Microbiology. 40: 1755-1760. PMID 11980956 DOI: 10.1128/Jcm.40.5.1755-1760.2002 |
0.605 |
|
| 2002 |
Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, et al. Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 419-20. PMID 11927505 |
0.336 |
|
| 2002 |
Castle PE, Lorincz AT, Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, Schussler JE, Schiffman M. Results of human papillomavirus DNA testing with the Hybrid Capture 2 assay are reproducible Journal of Clinical Microbiology. 40: 1088-1090. PMID 11880448 DOI: 10.1128/Jcm.40.3.1088-1090.2002 |
0.613 |
|
| 2002 |
Castle PE, Shields T, Kirnbauer R, Manos MM, Burk RD, Glass AG, Scott DR, Sherman ME, Schiffman M. Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity Sexually Transmitted Diseases. 29: 182-187. PMID 11875380 DOI: 10.1097/00007435-200203000-00009 |
0.74 |
|
| 2002 |
Scott DR, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, Sherman ME, Stoler MH, Kurman RJ, Kiviat NB, Manos MM, Schiffman M. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom. Cancer. 96: 14-20. PMID 11836698 DOI: 10.1002/cncr.10317 |
0.543 |
|
| 2002 |
Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). Journal of the National Cancer Institute. 94: 102-7. PMID 11792748 DOI: 10.1093/Jnci/94.2.102 |
0.702 |
|
| 2002 |
Ferris DG, Schiffman M, Litaker MS. Cervicography for triage of women with mi dly abnormal cervical cytology results Obstetrical & Gynecological Survey. 57: 86-87. DOI: 10.1097/00006254-200202000-00015 |
0.608 |
|
| 2002 |
Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL, Schiffman M, Castle PE. Persistent HPV infection is associated with a greater risk of developing cervical lesions than a single positive test Evidence-Based Obstetrics and Gynecology. 4: 148-149. DOI: 10.1054/Ebog.2002.0056 |
0.683 |
|
| 2001 |
Castle PE, Zemlo TR, Burk RD, Scott DR, Sherman ME, Lorincz AT, Kurman RJ, Glass AG, Rush BB, Liaw KL, Schiffman M. Cervical HPV DNA detection as a predictor of a recurrent SIL diagnosis among untreated women. Journal of Lower Genital Tract Disease. 5: 138-43. PMID 17050958 DOI: 10.1046/J.1526-0976.2001.53005.X |
0.703 |
|
| 2001 |
Schlecht NF, Franco EL, Rohan TE, Kjaer SK, Schiffman MH, Moscicki AB, Duffy SW. Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: determinants of reporting error at follow-up interviews. Journal of Epidemiology and Biostatistics. 6: 393-407. PMID 11822729 DOI: 10.1080/135952201753337149 |
0.322 |
|
| 2001 |
Wang SS, Wheeler CM, Hildesheim A, Schiffman M, Herrero R, Bratti MC, Sherman ME, Alfaro M, Hutchinson ML, Morales J, Lorincz A, Burk RD, Carrington M, Erlich HA, Apple RJ. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: Results from a population-based study in Costa Rica Journal of Infectious Diseases. 184: 1310-1314. PMID 11679920 DOI: 10.1086/324209 |
0.7 |
|
| 2001 |
Ferris DG, Schiffman M, Litaker MS. Cervicography for triage of women with mildly abnormal cervical cytology results American Journal of Obstetrics and Gynecology. 185: 939-943. PMID 11641682 DOI: 10.1067/Mob.2001.117485 |
0.536 |
|
| 2001 |
Sherman ME, Solomon D, Schiffman M. Qualification of ASCUS: A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage study American Journal of Clinical Pathology. 116: 386-394. PMID 11554167 DOI: 10.1309/Jm3V-U4Hp-W8Hj-68Xv |
0.573 |
|
| Show low-probability matches. |